Sensing the environment: Regulation of localand global homeostasis by the skin's neuroendocrine system

Advances in Anatomy Embryology and Cell Biology

Volumn 212, Issue , 2012, Pages 1-115

  Slominski, Andrzej T ^a   Zmijewski, Michal A ^b   Skobowiat, Cezary ^a   Zbytek, Blazej ^a   Slominski, Radomir M ^a,c   Steketee, Jeffery D ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOGENIC AMINE; ENDOCANNABINOID; NARCOTIC ANALGESIC AGENT; STEROID;

ANIMAL; ARTICLE; ENVIRONMENT; HOMEOSTASIS; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; NEUROSECRETION; SIGNAL TRANSDUCTION; SKIN;

ANALGESICS, OPIOID; ANIMALS; BIOGENIC AMINES; ENDOCANNABINOIDS; ENVIRONMENT; HOMEOSTASIS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROSECRETORY SYSTEMS; PITUITARY-ADRENAL SYSTEM; SIGNAL TRANSDUCTION; SKIN; STEROIDS;

EID: 84862848789     PISSN: 03015556     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-19683-6     Document Type: Article

References (544)

1. Abe M, Itoh MT, Miyata M, Ishikawa S, Sumi Y (1999) Detection of melatonin, its precursors and related enzyme activities in rabbit lens. Exp Eye Res 68:255-262 (Pubitemid 29090639)
2. Aberg KM, Radek KA, Choi EH, Kim DK, Demerjian M, Hupe M, Kerbleski J, Gallo RL, Ganz T, Mauro T, Feingold KR, Elias PM (2007) Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest 117:3339-3349 (Pubitemid 350096990)
3. Abrams DI, Couey P, Shade SB, Kelly ME, Benowitz NL (2011) Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther 90:844-851
4. Aguilera G, Rabadan-Diehl C, Nikodemova M (2001) Regulation of pituitary corticotropin releasing hormone receptors. Peptides 22:769-774 (Pubitemid 32397728)
5. Akerman S, Kaube H, Goadsby PJ (2004) Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. Br J Pharmacol 142:1354-1360 (Pubitemid 39178889)
6. Akhmetshina A, Dees C, Busch N, Beer J, Sarter K, Zwerina J, Zimmer A, Distler O, Schett G, Distler JH (2009) The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis. Arthritis Rheum 60:1129-1136
7. Albanesi C, Pastore S, Fanales-Belasio E, Girolomoni G (1998) Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes. Clin Exp Allergy 28:101-109 (Pubitemid 28053933)
8. Albro PW, Corbett JT, Schroeder JL (1994) Doubly allylic hydroperoxide formed in the reaction between sterol 5, 7-dienes and singlet oxygen. Photochem Photobiol 60:310-315
9. Amaya F, Shimosato G, Kawasaki Y, Hashimoto S, Tanaka Y, Ji RR, Tanaka M (2006) Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist. Pain 124(1-2):175-183 (Pubitemid 44176209)
10. Arck PC, Slominski A, Theoharides TC, Peters EM, Paus R (2006) Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 126:1697-1704 (Pubitemid 44086503)
11. Armario A (2010) Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome. Trends Pharmacol Sci 31:318-325
12. Arredondo J, Nguyen VT, Chernyavsky AI, Bercovich D, Orr-Urtreger A, Kummer W, Lips K, Vetter DE, Grando SA (2002) Central role of alpha7 nicotinic receptor in differentiation of the stratified squamous epithelium. J Cell Biol 159:325-336 (Pubitemid 35283401)
13. Arredondo J, Hall LL, Ndoye A, Chernyavsky AI, Jolkovsky DL, Grando SA (2003) Muscarinic acetylcholine receptors regulating cell cycle progression are expressed in human gingival keratinocytes. J Periodontal Res 38:79-89 (Pubitemid 37463601)
14. Ayoub MA, Couturier C, Lucas-Meunier E, Angers S, Fossier P, Bouvier M, Jockers R (2002) Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J Biol Chem 277:21522-21528 (Pubitemid 34952296)
15. Azmitia EC (2001) Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res Bull 56:413-424 (Pubitemid 34031777)
16. Azmitia EC (2007) Serotonin and brain: evolution, neuroplasticity, and homeostasis. Int Rev Neurobiol 77:31-56
17. Azmitia EC (2010) Evolution of serotonin: sunlight to suicide. In: Muller CP, Jacobs BL (eds) Handbook of the behavioral neurobiology of serotonin. Academic Press, Burlington, MA
18. Bangha E, Elsner P, Kistler GS (1996) Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose response study. Arch Dermatol Res 288:522-526 (Pubitemid 26280701)
19. Bangha E, Elsner P, Kistler GS (1997) Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). Influence of the application time point. Dermatology 195:248-252 (Pubitemid 27482886)
20. Barr GA, Zadina JE (1999) Maturation of endomorphin-2 in the dorsal horn of the medulla and spinal cord of the rat. Neuroreport 10:3857-3860 (Pubitemid 30004846)
21. Bartsch C, Bartsch H, Karasek M (2002) Melatonin in clinical oncology. Neuroendocrinol Lett 23 (Suppl 1):30-38 (Pubitemid 34495379)
22. Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182-217
23. Becker-Andre M, Wiesenberg I, Schaeren-Wiemers N, Andre E, Missbach M, Saurat JH, Carlberg C (1994) Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem 269:28531-28534 (Pubitemid 24366678)
24. Becklund BR, Severson KS, Vang SV, Deluca HF (2010) UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proc Natl Acad Sci USA 107:6418-6423
25. Belon PE (1985) UVA exposure and pituitary secretion. Variations of human lipotropin concentrations (beta LPH) after UVA exposure. Photochem Photobiol 42:327-329
26. Benton T, Lynch K, Dube B, Gettes DR, Tustin NB, Ping Lai J, Metzger DS, Blume J, Douglas SD, Evans DL (2010) Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication. Psychosom Med 72:925-932
27. Bergmann M, Sautner T (2002) Immunomodulatory effects of vasoactive catecholamines. Wien Klin Wochenschr 114:752-761
28. Bergquist J, Josefsson E, Tarkowski A, Ekman R, Ewing A (1997) Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis. Electrophoresis 18:1760-1766 (Pubitemid 27451830)
29. Berwick M, Armstrong BK, Ben-Porat L, Fine J, Kricker A, Eberle C, Barnhill R (2005) Sun exposure and mortality from melanoma. J Natl Cancer Inst 97:195-199 (Pubitemid 40277369)
30. Besedovsky HO, Rey AD (2007) Physiology of psychoneuroimmunology: a personal view. Brain Behav Immun 21:34-44 (Pubitemid 44854450)
31. Besser MJ, Ganor Y, Levite M (2005) Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both. J Neuroimmunol 169:161-171 (Pubitemid 41528789)
32. Betten A, Dahlgren C, Hermodsson S, Hellstrand K (2001) Serotonin protects NK cells against oxidatively induced functional inhibition and apoptosis. J Leukoc Biol 70:65-72 (Pubitemid 32613664)
33. Bigliardi PL, Bigliardi-Qi M, Buechner S, Rufli T (1998) Expression of mu-opiate receptor in human epidermis and keratinocytes. J Invest Dermatol 111:297-301 (Pubitemid 28354719)
34. Bigliardi PL, Tobin DJ, Gaveriaux-Ruff C, Bigliardi-QiM(2009) Opioids and the skin-where do we stand? Exp Dermatol 18:424-430
35. Bikle DD (2010) Vitamin D and the skin. J Bone Miner Metab 28:117-130
36. Bikle DD (2011a) Vitamin D metabolism and function in the skin. Mol Cell Endocrinol 347:80-89
37. Bikle DD (2011b) The vitamin D receptor: a tumor suppressor in skin. Discov Med 11:7-17
38. Bikle DD (2011c) Vitamin D: an ancient hormone. Exp Dermatol 20:7-13
39. Billoni N, Buan B, Gautier B, Gaillard O, Mahe YF, Bernard BA (2000) Thyroid hormone receptor beta1 is expressed in the human hair follicle. Br J Dermatol 142:645-652 (Pubitemid 30226377)
40. Biro T, Toth BI, Hasko G, Paus R, Pacher P (2009) The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci 30:411-420
41. Bissonnette EY, Befus AD (1997) Anti-inflammatory effect of beta 2-agonists: inhibition of TNFalpha release from human mast cells. J Allergy Clin Immunol 100:825-831 (Pubitemid 28299003)
42. Blalock JE, Smith EM (2007) Conceptual development of the immune system as a sixth sense. Brain Behav Immun 21:23-33 (Pubitemid 44854449)
43. Blau N, Van Spronsen FJ, Levy HL (2010) Phenylketonuria. Lancet 376:1417-1427
44. Blazquez C, Carracedo A, Barrado L, Real PJ, Fernandez-Luna JL, Velasco G, Malumbres M, Guzman M (2006) Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J 20:2633-2635
45. Bodo E, Kromminga A, Biro T, Borbiro I, Gaspar E, Zmijewski MA, Van Beek N, Langbein L, Slominski AT, Paus R (2009) Human female hair follicles are a direct, nonclassical target for thyroid-stimulating hormone. J Invest Dermatol 129:1126-1139
46. Bodo E, Kany B, Gaspar E, Knuver J, Kromminga A, Ramot Y, Biro T, Tiede S, Van Beek N, Poeggeler B, Meyer KC, Wenzel BE, Paus R (2010) Thyroid-stimulating hormone, a novel, locally produced modulator of human epidermal functions, is regulated by thyrotropinreleasing hormone and thyroid hormones. Endocrinology 151:1633-1642
47. Bolognia J, Jorizzo Jl, Rapini RP (2008) Dermatology. Mosby-Elsevier, Philadelphia, PA
48. Borzsei R, Pozsgai G, Bagoly T, Elekes K, Pinter E, Szolcsanyi J, Helyes Z (2008) Inhibitory action of endomorphin-1 on sensory neuropeptide release and neurogenic inflammation in rats and mice. Neuroscience 152:82-88
49. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, Sparso T, Holmkvist J, Marchand M et al (2009) A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 41:89-94
50. Branchek TA, Mawe GM, Gershon MD (1988) Characterization and localization of a peripheral neural 5-hydroxytryptamine receptor subtype (5-HT1P) with a selective agonist, 3H-5-hydroxyindalpine. J Neurosci 8:2582-2595
51. Brozyna AA, Jozwicki W, Janjetovic Z, Slominski AT (2011) Expression of vitamin D receptor decreases during progression of pigmented skin lesions. Hum Pathol 42:618-631
52. Bubenik GA (2002) Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 47:2336-2348 (Pubitemid 35205309)
53. Buchli R, Ndoye A, Arredondo J, Webber RJ, Grando SA (2001) Identification and characterization of muscarinic acetylcholine receptor subtypes expressed in human skin melanocytes. Mol Cell Biochem 228:57-72 (Pubitemid 34121437)
54. Bujalska I, Shimojo M, Howie A, Stewart PM (1997) Human 11 beta-hydroxysteroid dehydrogenase: studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue. Steroids 62:77-82 (Pubitemid 27066989)
55. Bujalska IJ, Walker EA, Hewison M, Stewart PM (2002) A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. J Clin Endocrinol Metab 87:1205-1210 (Pubitemid 36121089)
56. Cahill GM, Besharse JC (1989) Retinal melatonin is metabolized within the eye of Xenopus laevis. Proc Natl Acad Sci USA 86:1098-1102 (Pubitemid 19056298)
57. Capsoni S, Viswanathan M, De Oliveira AM, Saavedra JM (1994) Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis. Endocrinology 135:373-378 (Pubitemid 24203840)
58. Carlberg C, Hooft Van Huijsduijnen R, Staple JK, Delamarter JF, Becker-AndreM(1994) RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol Endocrinol 8:757-770 (Pubitemid 24179668)
59. Carlton SM, Coggeshall RE (1997) Immunohistochemical localization of 5-HT2A receptors in peripheral sensory axons in rat glabrous skin. Brain Res 763:271-275 (Pubitemid 27364450)
60. Carrier Y, Ma HL, Ramon HE, Napierata L, Small C, O'toole M, Young DA, Fouser LA, Nickerson-Nutter C, Collins M, Dunussi-Joannopoulos K, Medley QG (2011) Inter-regulation of Th17 cytokines and the il-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J Invest Dermatol 131:2428-2437
61. Carrillo-Vico A, Calvo JR, Abreu P, Lardone PJ, Garcia-Maurino S, Reiter RJ, Guerrero JM (2004) Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J 18:537-539
62. Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huffman JW, Jorcano JL, Guzman M (2003) Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 111:43-50 (Pubitemid 36134847)
63. Chakraborty AK, Funasaka Y, Slominski A, Bolognia J, Sodi S, Ichihashi M, Pawelek JM (1999) UV light and MSH receptors. Ann N Y Acad Sci 885:100-116
64. Chen J, Hoffman BB, Isseroff RR (2002) Beta-adrenergic receptor activation inhibits keratinocyte migration via a cyclic adenosine monophosphate-independent mechanism. J Invest Dermatol 119:1261-1268 (Pubitemid 36005607)
65. Chernyavsky AI, Arredondo J, Marubio LM, Grando SA (2004a) Differential regulation of keratinocyte chemokinesis and chemotaxis through distinct nicotinic receptor subtypes. J Cell Sci 117:5665-5679 (Pubitemid 40012212)
66. Chernyavsky AI, Arredondo J, Wess J, Karlsson E, Grando SA (2004b) Novel signaling pathways mediating reciprocal control of keratinocyte migration and wound epithelialization through M3 and M4 muscarinic receptors. J Cell Biol 166:261-272 (Pubitemid 38988778)
67. Chernyavsky AI, Arredondo J, Piser T, Karlsson E, Grando SA (2008) Differential coupling of M1 muscarinic and alpha7 nicotinic receptors to inhibition of pemphigus acantholysis. J Biol Chem 283:3401-3408
68. Chesnokova V, Melmed S (2002) Minireview: neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 143:1571-1574 (Pubitemid 34415869)
69. Chignell CF, Kukielczak BM, Sik RH, Bilski PJ, He YY (2006) Ultraviolet al. sensitivity in Smith-Lemli-Opitz syndrome: possible involvement of cholesta-5, 7, 9(11)-trien-3 beta-ol. Free Radic Biol Med 41:339-346 (Pubitemid 43928508)
70. Chizhmakov I, Yudin Y, Mamenko N, Prudnikov I, Tamarova Z, Krishtal O (2005) Opioids inhibit purinergic nociceptors in the sensory neurons and fibres of rat via a G protein-dependent mechanism. Neuropharmacology 48:639-647 (Pubitemid 40462404)
71. Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362
72. Chrousos GP, Gold PW (1992) The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267:1244-1252
73. Cianfarani F, Baldini E, Cavalli A, Marchioni E, Lembo L, Teson M, Persechino S, Zambruno G, Ulisse S, Odorisio T, D'armiento M (2010) TSH receptor and thyroid-specific gene expression in human skin. J Invest Dermatol 130:93-101
74. Cirillo N, Prime SS (2011) Keratinocytes synthesize and activate cortisol. J Cell Biochem 112:1499-1505
75. Cloez-Tayarani I, Changeux JP (2007) Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol 81:599-606 (Pubitemid 46393537)
76. Coburn SP, Slominski A, Mahuren JD, Wortsman J, Hessle L, Millan JL (2003) Cutaneous metabolism of vitamin B-6. J Invest Dermatol 120:292-300 (Pubitemid 36513080)
77. Connell K, Bolton N, Olsen D, Piomelli D, HohmannAG(2006)Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia. Neurosci Lett 397:180-184
78. Contreras-Jurado C, Garcia-Serrano L, Gomez-Ferreria M, Costa C, Paramio JM, Aranda A (2011) The thyroid hormone receptors as modulators of skin proliferation and inflammation. J Biol Chem 286:24079-24088
79. Costa B, Pini S, Gabelloni P, Da Pozzo E, Abelli M, Lari L, Preve M, Lucacchini A, Cassano GB, Martini C (2009) The spontaneous Ala147Thr amino acid substitution within the translocator protein influences pregnenolone production in lymphomonocytes of healthy individuals. Endocrinology 150:5438-5445
80. Cotecchia S (2010) The alpha1-adrenergic receptors: diversity of signaling networks and regulation. J Recept Signal Transduct Res 30:410-419
81. Dai J, Ram PT, Yuan L, Spriggs LL, Hill SM (2001) Transcriptional repression of RORalpha activity in human breast cancer cells by melatonin. Mol Cell Endocrinol 176:111-120 (Pubitemid 32454942)
82. Davies E, MacKenzie SM (2003) Extra-adrenal production of corticosteroids. Clin Exp Pharmacol Physiol 30:437-445 (Pubitemid 36836558)
83. Davis SC, Clark S, Hayes JR, Green TL, Gruetter CA (2011) Up-regulation of histidine decarboxylase expression and histamine content in B16F10 murine melanoma cells. Inflamm Res 60:55-61
84. De Fabiani E, Caruso D, Cavaleri M, Galli Kienle M, Galli G (1996) Cholesta-5, 7, 9(11)-trien-3 beta-ol found in plasma of patients with Smith-Lemli-Opitz syndrome indicates formation of sterol hydroperoxide. J Lipid Res 37:2280-2287
85. Denzer N, Vogt T, Reichrath J (2011) Vitamin D receptor (VDR) polymorphisms and skin cancer: a systematic review. Dermatoendocrinology 3:205-210
86. Dijkstra D, Leurs R, Chazot P, Shenton FC, Stark H, Werfel T, Gutzmer R (2007) Histamine downregulates monocyte CCL2 production through the histamine H4 receptor. J Allergy Clin Immunol 120:300-307 (Pubitemid 47102370)
87. Ding Z, Jiang M, Li S, Zhang Y (1995) Vascular barrier-enhancing effect of an endogenous betaadrenergic agonist. Inflammation 19:1-8
88. Do Rego JL, Seong JY, Burel D, Leprince J, Luu-The V, Tsutsui K, Tonon MC, Pelletier G, Vaudry H (2009) Front Neuroendocrinol. 30:259-301
89. Doshi DN, Blyumin ML, Kimball AB (2008) Cutaneous manifestations of thyroid disease. Clin Dermatol 26:283-287 (Pubitemid 351978198)
90. Draper N, Stewart PM (2005) 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J Endocrinol 186:251-271 (Pubitemid 41167396)
91. Dreher F, Gabard B, Schwindt DA, Maibach HI (1998) Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: a human study in vivo. Br J Dermatol 139:332-339 (Pubitemid 28389414)
92. Dreher F, Denig N, Gabard B, Schwindt DA, Maibach HI (1999) Effect of topical antioxidants on UV-induced erythema formation when administered after exposure. Dermatol 198:52-55 (Pubitemid 29086335)
93. Drummond PD, Skipworth S, Finch PM (1996) alpha 1-adrenoceptors in normal and hyperalgesic human skin. Clin Sci (Lond) 91:73-77 (Pubitemid 26238299)
94. Dubocovich ML, Markowska M (2005) Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 27:101-110 (Pubitemid 41558442)
95. Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, Masana MI (2003) Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci 8:d1093-d1108
96. Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J (2010) International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 62:343-380
97. Dumont M, Luu-The V, Dupont E, Pelletier G, Labrie F (1992) Characterization, expression, and immunohistochemical localization of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase in human skin. J Invest Dermatol 99:415-421
98. Dvorak M, Watkinson A, Mcglone F, Rukwied R (2003) Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin. Inflamm Res 52:238-245 (Pubitemid 36791930)
99. Eisenhofer G, Tian H, Holmes C, Matsunaga J, Roffler-Tarlov S, Hearing VJ (2003) Tyrosinase: a developmentally specific major determinant of peripheral dopamine. FASEB J 17:1248-1255 (Pubitemid 36775771)
100. Ellerhorst JA, Sendi-Naderi A, Johnson MK, Cooke CP, Dang SM, Diwan AH (2006) Human melanoma cells express functional receptors for thyroid-stimulating hormone. Endocr Relat Cancer 13:1269-1277 (Pubitemid 46212579)
101. Ellerhorst JA, Diwan AH, Dang SM, Uffort DG, Johnson MK, Cooke CP, Grimm EA (2010) Promotion of melanoma growth by the metabolic hormone leptin. Oncol Rep 23:901-907
102. Ermak G, Slominski A (1997) Production of POMC, CRH-, ACTH-and a-MSH-receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin. J Invest Dermatol 108:160-167
103. Falck B, Bendsoe N, Ronquist G (2004) Mediated exodus of L-dopa from human epidermal Langerhans cells. Amino Acids 26:133-138 (Pubitemid 38519702)
104. Fallahzadeh MK, Namazi MR (2009) Opioid-mediated immunosuppression as a novel mechanism for the immunomodulatory effect of ultraviolet radiation. Indian J Dermatol Venereol Leprol 75:622-623
105. Fazal N, Slominski A, Choudhry MA, Wei ET, Sayeed MM (1998) Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Lett 435:187-190 (Pubitemid 28436580)
106. Felig P, Frohman LA (2001) Endocrinology and metabolism. McGraw-Hill, New York, NY
107. Feng K, Zhang RY, Wu LZ, Tu B, Peng ML, Zhang LP, Zhao D, Tung CH (2006) Photooxidation of olefins under oxygen in platinum(II) complex-loaded mesoporous molecular sieves. J Am Chem Soc 128:14685-14690 (Pubitemid 44749871)
108. Fichna J, Janecka A, Costentin J, Do Rego JC (2007) The endomorphin system and its evolving neurophysiological role. Pharmacol Rev 59:88-123 (Pubitemid 46333997)
109. Field S, Newton-Bishop JA (2011) Melanoma and vitamin D. Mol Oncol 5:197-214
110. Finn DP (2010) Endocannabinoid-mediated modulation of stress responses: physiological and pathophysiological significance. Immunobiol 215:629-646
111. Finocchiaro LM, Nahmod VE, Launay JM (1991) Melatonin biosynthesis and metabolism in peripheral blood mononuclear leucocytes. Biochem J 280(Pt 3):727-731
112. Fischer J, Bouadjar B, Heilig R, Huber M, Lefevre C, Jobard F, Macari F, Bakija-Konsuo A, Ait-Belkacem F, Weissenbach J, Lathrop M, Hohl D, Prud'homme JF (2001) Mutations in the gene encoding SLURP-1 in Mal de Meleda. Hum Mol Genet 10:875-880 (Pubitemid 32331598)
113. Fischer TW, Scholz G, Knoll B, Hipler UC, Elsner P (2002) Melatonin suppresses reactive oxygen species in UV-irradiated leukocytes more than vitamin C and trolox. Skin Pharmacol Appl Skin Physiol 15:367-373
114. Fischer TW, Burmeister G, Schmidt HW, Elsner P (2004) Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. Br J Dermatol 150:341-345 (Pubitemid 38352474)
115. Fischer TW, Sweatman TW, Semak I, Sayre RM, Wortsman J, Slominski A (2006a) Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems. FASEB J 20:1564-1566
116. Fischer TW, Zbytek B, Sayre RM, Apostolov EO, Basnakian AG, Sweatman TW, Wortsman J, Elsner P, Slominski A (2006b) Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J Pineal Res 40:18-26
117. Fischer TW, Zmijewski MA, Zbytek B, Sweatman TW, Slominski RM, Wortsman J, Slominski A (2006c) Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int J Oncol 29:665-672
118. Fischer TW, Slominski A, Tobin DJ, Paus R (2008a) Melatonin and the hair follicle. J Pineal Res 44:1-15 (Pubitemid 350231105)
119. Fischer TW, Slominski A, Zmijewski MA, Reiter RJ, Paus R (2008b) Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair. Exp Dermatol 17:713-730
120. Fischer TW, Zmijewski MA, Wortsman J, Slominski A (2008c) Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes. J Pineal Res 44:397-407 (Pubitemid 351533524)
121. Fitzpatrick TB, Wolff K, Freedberg IM, Austen KF (1993) Dermatology in general medicine. McGraw Hill, New York
122. Fitzsimons C, Engel N, Policastro L, Duran H, Molinari B, Rivera E (2002) Regulation of phospholipase C activation by the number of H(2) receptors during Ca(2+)-induced differentiation of mouse keratinocytes. Biochem Pharmacol 63:1785-1796 (Pubitemid 34603443)
123. Fromy B, Sigaudo-Roussel D, Gaubert-Dahan ML, Rousseau P, Abraham P, Benzoni D, Berrut G, Saumet JL (2010) Aging-associated sensory neuropathy alters pressure-induced vasodilation in humans. J Invest Dermatol 130:849-855
124. Fujii E, Irie K, Uchida Y, Tsukahara F, Muraki T (1994) Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin. Naunyn Schmiedebergs Arch Pharmacol 350:361-364 (Pubitemid 24290546)
125. Fujimoto S, Komine M, Karakawa M, Uratsuji H, Kagami S, Tada Y, Saeki H, Ohtsuki M, Tamaki K (2011) Histamine differentially regulates the production of Th1 and Th2 chemokines by keratinocytes through histamine H1 receptor. Cytokine 54:191-199
126. Funasaka Y, Sato H, Chakraborty AK, Ohashi A, Chrousos GP, Ichihashi M (1999) Expression of proopiomelanocortin, corticotropin-releasing hormone (CRH), and CRH receptor in melanoma cells, nevus cells, and normal human melanocytes. J Investig Dermatol Symp Proc 4:105-109 (Pubitemid 29489032)
127. Fuziwara S, Suzuki A, Inoue K, Denda M (2005) Dopamine D2-like receptor agonists accelerate barrier repair and inhibit the epidermal hyperplasia induced by barrier disruption. J Invest Dermatol 125:783-789
128. Gambichler T, Bader A, Vojvodic M, Bechara FG, Sauermann K, Altmeyer P, Hoffmann K (2002) Impact of UVA exposure on psychological parameters and circulating serotonin and melatonin. BMC Dermatol 2:6
129. Garssen J, De Gruijl F, Mol D, De Klerk A, Roholl P, Van Loveren H (2001) UVA exposure affects UVB and cis-urocanic acid-induced systemic suppression of immune responses in Listeria monocytogenes-infected Balb/c mice. Photochem Photobiol 73:432-438
130. Gaspar E, Hardenbicker C, Bodo E, Wenzel B, Ramot Y, Funk W, Kromminga A, Paus R (2010) Thyrotropin releasing hormone (TRH): a new player in human hair-growth control. FASEB J 24:393-403
131. Gaspar E, Nguyen-Thi KT, Hardenbicker C, Tiede S, Plate C, Bodo E, Knuever J, Funk W, Biro T, Paus R (2011) Thyrotropin-releasing hormone selectively stimulates human hair follicle pigmentation. J Invest Dermatol 131:2368-2377
132. Gaudet SJ, Slominski A, Etminan M, Pruski D, Paus R, MaA N (1993) Identification and characterization of two isozymic forms of arylamine N-acetyltransferase in Syrian hamster skin. J Invest Dermatol 101:660-665 (Pubitemid 23322020)
133. Ghoghawala SY, Mannis MJ, Pullar CE, Rosenblatt MI, Isseroff RR (2008) Beta2-adrenergic receptor signaling mediates corneal epithelial wound repair. Invest Ophthalmol Vis Sci 49:1857-1863
134. Gibbins IL (1992) Vasoconstrictor, vasodilator and pilomotor pathways in sympathetic ganglia of guinea-pigs. Neurosci 47:657-672
135. Gillbro JM, Marles LK, Hibberts NA, Schallreuter KU (2004) Autocrine catecholamine biosynthesis and the beta-adrenoceptor signal promote pigmentation in human epidermal melanocytes. J Invest Dermatol 123:346-353 (Pubitemid 38951830)
136. Giustizieri ML, Albanesi C, Fluhr J, Gisondi P, Norgauer J, Girolomoni G (2004) H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 114:1176-1182 (Pubitemid 39469162)
137. Gombart AF, Borregaard N, Koeffler HP (2005) Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3. FASEB J 19:1067-1077 (Pubitemid 40946432)
138. Grace MS, Cahill GM, Besharse JC (1991) Melatonin deacetylation: retinal vertebrate class distribution and Xenopus laevis tissue distribution. Brain Res 559:56-63
139. Graef S, Schonknecht P, Sabri O, Hegerl U (2011) Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings. Psychopharmacol (Berl) 215:205-229
140. Grammatopoulos DK, Chrousos GP (2002) Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab 13:436-444 (Pubitemid 36733938)
141. Grammatopoulos DK, Dai Y, Randeva HS, Levine MA, Karteris E, Easton AJ, Hillhouse EW (1999) A novel spliced variant of the type 1 corticotropin- releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes. Mol Endocrinol 13:2189-2202 (Pubitemid 30637277)
142. Grando SA (1997) Biological functions of keratinocyte cholinergic receptors. J Investig Dermatol Symp Proc 2:41-48 (Pubitemid 27323376)
143. Grando SA (2006) Cholinergic control of epidermal cohesion. Exp Dermatol 15:265-282 (Pubitemid 43349068)
144. Grando SA, Kist DA, Qi M, Dahl MV (1993) Human keratinocytes synthesize, secrete, and degrade acetylcholine. J Invest Dermatol 101:32-36 (Pubitemid 23213008)
145. Grando SA, Zelickson BD, Kist DA, Weinshenker D, Bigliardi PL, Wendelschafer-Crabb G, Kennedy WR, Dahl MV (1995) Keratinocyte muscarinic acetylcholine receptors: immunolocalization and partial characterization. J Invest Dermatol 104:95-100
146. Grando SA, Horton RM, Mauro TM, Kist DA, Lee TX, Dahl MV (1996) Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation. J Invest Dermatol 107:412-418 (Pubitemid 26284352)
147. Grando SA, Pittelkow MR, SchallreuterKU (2006)Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance. J Invest Dermatol 126:1948-1965
148. Gschwandtner M, Purwar R, Wittmann M, Baumer W, Kietzmann M, Werfel T, Gutzmer R (2008) Histamine upregulates keratinocyte MMP-9 production via the histamine H1 receptor. J Invest Dermatol 128:2783-2791
149. Gschwandtner M, Mommert S, Kother B, Werfel T, Gutzmer R (2011) The histamine H4 receptor is highly expressed on plasmacytoid dendritic cells in psoriasis and histamine regulates their cytokine production and migration. J Invest Dermatol 131:1668-1676
150. Guindon J, Hohmann AG (2009) The endocannabinoid system and pain. CNS Neurol Disord Drug Targets 8:403-421
151. Guryev O, Carvalho RA, Usanov S, Gilep A, Estabrook RW (2003) A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1). Proc Natl Acad Sci USA 100:14754-14759 (Pubitemid 37517963)
152. Gutzmer R, Mommert S, Gschwandtner M, Zwingmann K, Stark H, Werfel T (2009) The histamine H4 receptor is functionally expressed on T(H)2 cells. J Allergy Clin Immunol 123:619-625
153. Haak-Frendscho M, Darvas Z, Hegyesi H, Karpati S, Hoffman RL, Laszlo V, Bencsath M, Szalai C, Furesz J, Timar J, Bata-Csorgo Z, Szabad G, Pivarcsi A, Pallinger E, Kemeny L, Horvath A, Dobozy A, Falus A (2000) Histidine decarboxylase expression in human melanoma. J Invest Dermatol 115:345-352
154. Hannen RF, Michael AE, Jaulim A, Bhogal R, Burrin JM, Philpott MP (2011) Steroid synthesis by primary human keratinocytes; implications for skin disease. Biochem Biophys Res Commun 404:62-67
155. Hara MR, Kovacs JJ, Whalen EJ, Rajagopal S, Strachan RT, Grant W, Towers AJ, Williams B, Lam CM, Xiao K, Shenoy SK, Gregory SG, Ahn S, Duckett DR, Lefkowitz RJ (2011) A stress response pathway regulates DNA damage through beta(2)-adrenoreceptors and beta-arrestin-1. Nature 477:349-353
156. Harada K, Ohashi K, Fujimura A, Kumagai Y, Ebihara A (1996) Effect of alpha 1-adrenoceptor antagonists, prazosin and urapidil, on a finger skin vasoconstrictor response to cold stimulation. Eur J Clin Pharmacol 49:371-375
157. Hardeland R, Backhaus C, Fadavi A (2007) Reactions of the NO redox forms NO+, *NO and HNO (protonated NO-) with the melatonin metabolite N1-acetyl-5-methoxykynuramine. J Pineal Res 43:382-388 (Pubitemid 47512270)
158. Hardeland R, Tan DX, Reiter RJ (2009) Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 47:109-126
159. Hardeland R, Cardinali DP, Srinivasan V, Spence DW, Brown GM, Pandi-Perumal SR (2011) Melatonin-a pleiotropic, orchestrating regulator molecule. Prog Neurobiol 93:350-384
160. Harrington LE, Mangan PR, Weaver CT (2006) Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 18:349-356
161. Harrington CR, Beswick TC, Graves M, Jacobe HT, Harris TS, Kourosh S, Devous Sr MD, Adinoff B (2012) Activation of the mesostriatal reward pathway with exposure to ultraviolet radiation (UVR) vs. sham UVR in frequent tanners: a pilot study. Addict Biol. 17:680-6
162. Hassan AH, Pzewlocki R, Herz A, Stein C (1992) Dynorphin, a preferential ligand for kappaopioid receptors, is present in nerve fibers and immune cells within inflamed tissue of the rat. Neurosci Lett 140:85-88
163. Hasse S, Chernyavsky AI, Grando SA, PausR(2007)TheM4 muscarinic acetylcholine receptor plays a key role in the control of murine hair follicle cycling and pigmentation. Life Sci 80:2248-2252 (Pubitemid 46818260)
164. Hein L (2006) Adrenoceptors and signal transduction in neurons. Cell Tissue Res 326:541-551 (Pubitemid 44435825)
165. Hemley CF, Mccluskey A, Keller PA (2007) Corticotropin releasing hormone-a GPCR drug target. Curr Drug Targets 8:105-115 (Pubitemid 46043902)
166. Hickman AB, Namboodiri MA, Klein DC, Dyda F (1999) The structural basis of ordered substrate binding by serotonin N-acetyltransferase: enzyme complex at 1.8 A resolution with a bisubstrate analog. Cell 97:361-369
167. Hill SM, Frasch T, Xiang S, Yuan L, Duplessis T, Mao L (2009) Molecular mechanisms of melatonin anticancer effects. Integr Cancer Ther 8:337-346
168. Hillhouse EW, Grammatopoulos DK (2006) The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev 27:260-286
169. Hillhouse EW, Randeva H, Ladds G, Grammatopoulos D (2002) Corticotropin-releasing hormone receptors. Biochem Soc Trans 30:428-432 (Pubitemid 35001570)
170. Hirata F, Hayaishi O, Tokuyama T, Seno S (1974) In vitro and in vivo formation of two new metabolites of melatonin. J Biol Chem 249:1311-1313
171. Holick MF (2003) Vitamin D: a millenium perspective. J Cell Biochem 88:296-307 (Pubitemid 36119902)
172. Holick MF (2008) Sunlight, UV-radiation, vitamin D and skin cancer: how much sunlight do we need? Adv Exp Med Biol 624:1-15
173. Holick MF, Clark MB (1978) The photobiogenesis and metabolism of vitamin D. Fed Proc 37:2567-2574
174. Holick MF, Tian XQ, Allen M(1995) Evolutionary importance for the membrane enhancement of the production of vitamin D3 in the skin of poikilothermic animals. Proc Natl Acad Sci USA 92:3124-3126
175. Holtzmann H, Altmeyer P, Schultz-Amling W (1982) Der Einfluss Ultravioletter Strahlen auf die Hypothalamus-Hypophysenachse des Menschen. Acta Dermatol 8:119-123 (Pubitemid 12046035)
176. Holtzmann HP, Altmeyer L, Stohr CGN (1983) Die Beeinflussung des alpha-MSH durch UVABestrahlunger der Haut-ein Funktionstest. Hautarzt 34:294-297
177. Hou P, Liu D, Ji M, Liu Z, Engles JM, Wahl RL, Xing M (2009) Induction of thyroid gene expression and radioiodine uptake in melanoma cells: novel therapeutic implications. PLoS One 4:e6200
178. Howe J, Costantino R, Slominski A (1991) On the putative mechanism of induction and regulation of melanogenesis by L-tyrosine. Acta Derm Venereol 71:150-152
179. Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533-554 (Pubitemid 34219205)
180. Hsueh CM, Chen SF, Lin RJ, Chao HJ (2002) Cholinergic and serotonergic activities are required in triggering conditioned NK cell response. J Neuroimmunol 123:102-111
181. Hu DN (2000) Regulation of growth and melanogenesis of uveal melanocytes. Pigment Cell Res 13(Suppl 8):81-86
182. Hu DN, Woodward DF, Mccormick SA (2000) Influence of autonomic neurotransmitters on human uveal melanocytes in vitro. Exp Eye Res 71:217-224
183. Huang MP, Rodgers KA, O'mara R, Mehta M, Abuzahra HS, Tannenbaum AD, Persons K, Holick MF, Safer JD (2011) The thyroid hormone degrading type 3 deiodinase is the primary deiodinase active in murine epidermis. Thyroid 21:1263-1268
184. Huttunen M, Hyttinen M, Nilsson G, Butterfield JH, Horsmanheimo M, Harvima IT (2001) Inhibition of keratinocyte growth in cell culture and whole skin culture by mast cell mediators. Exp Dermatol 10:184-192 (Pubitemid 32492481)
185. Ibraheem M, Galbraith H, Scaife J, Ewen S (1994) Growth of secondary hair follicles of the Cashmere goat in vitro and their response to prolactin and melatonin. J Anat 185(Pt 1):135-142 (Pubitemid 24237940)
186. Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A, Davar G, Makriyannis A, Vanderah TW, Mata HP, Malan TP Jr (2005) CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci USA 102:3093-3098 (Pubitemid 40299921)
187. Ingordo V, Gentile C, Iannazzone SS, Cusano F, Naldi L (2011) Vitiligo and autoimmunity: an epidemiological study in a representative sample of young Italian males. J Eur Acad Dermatol Venereol 25:105-109
188. Irving AJ, Rae MG, Coutts AA (2002) Cannabinoids in the brain. Scientific World J 2:632-648
189. Ishikawa T, Kanda N, Hau CS, Tada Y, Watanabe S (2009) Histamine induces human betadefensin-3 production in human keratinocytes. J Dermatol Sci 56:121-127
190. Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, Kees F, Straub RH, Paus R (2005) Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J 19:1332-1334 (Pubitemid 41113740)
191. Itoh MT, Shinozawa T, Sumi Y (1999) Circadian rhythms of melatonin-synthesizing enzyme activities and melatonin levels in planarians. Brain Res 830:165-173 (Pubitemid 29251723)
192. Itoi K, Jiang YQ, Iwasaki Y, Watson SJ (2004) Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus. J Neuroendocrinol 16:348-355 (Pubitemid 38618652)
193. Iyengar B (1989) Modulation of melanocytic activity by acetylcholine. Acta Anat (Basel) 136:139-141 (Pubitemid 19263771)
194. Jangi SM, Diaz-Perez JL, Ochoa-Lizarralde B, Martin-Ruiz I, Asumendi A, Perez-Yarza G, Gardeazabal J, Diaz-Ramon JL, Boyano MD (2006) H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells. Carcinogenesis 27:1787-1796 (Pubitemid 44288661)
195. Janjetovic Z, Zmijewski MA, Tuckey RC, Deleon DA, Nguyen MN, Pfeffer LM, SlominskiAT (2009) 20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NFkappaB activity by increasing IkappaB alpha levels in human keratinocytes. PLoS One 4:e5988
196. Janjetovic Z, Tuckey RC, Nguyen MN, Thorpe EM Jr, Slominski AT (2010) 20, 23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes. J Cell Physiol 223:36-48
197. Janjetovic Z, Brozyna AA, Tuckey RC, Kim TK, Nguyen MN, Jozwicki W, Pfeffer SR, Pfeffer LM, Slominski AT (2011) High basal NF-kB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives. Br J Cancer 105:1874-1884
198. Jankowska E, Schomburg ED (1998) A leu-enkephalin depresses transmission from muscle and skin non-nociceptors to first-order feline spinal neurones. J Physiol 510(Pt 2):513-525 (Pubitemid 28370463)
199. Jin D, He P, You X, Zhu X, Dai L, He Q, Liu C, Hui N, Sha J, Ni X (2007) Expression of corticotropin-releasing hormone receptor type 1 and type 2 in human pregnant myometrium. Reprod Sci 14:568-577 (Pubitemid 351168790)
200. Jockers R, Maurice P, Boutin JA, Delagrange P (2008) Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Br J Pharmacol 154:1182-1195 (Pubitemid 351992057)
201. Jordan B, Devi LA (1998) Molecular mechanisms of opioid receptor signal transduction. Br J Anaesth 81:12-19 (Pubitemid 28359261)
202. Jordan BA, Cvejic S, Devi LA (2000) Opioids and their complicated receptor complexes. Neuropsychopharmacology 23:S5-S18
203. Jung B, Ahmad N (2006) Melatonin in cancer management: progress and promise. Cancer Res 66:9789-9793 (Pubitemid 44672026)
204. Kallen J, Schlaeppi JM, Bitsch F, Delhon I, Fournier B (2004) Crystal structure of the human RORalpha ligand binding domain in complex with cholesterol sulfate at 2.2 A. J Biol Chem 279:14033-14038 (Pubitemid 38468938)
205. Kamdem LK, Hamilton L, Cheng C, Liu W, Yang W, Johnson JA, Pui CH, Relling MV (2008) Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia. Pharmacogenet Genomics 18:507-514 (Pubitemid 351769918)
206. Kanda N, Watanabe S (2003) Histamine enhances the production of nerve growth factor in human keratinocytes. J Invest Dermatol 121:570-577 (Pubitemid 37072270)
207. Kanda N, Watanabe S (2004) Histamine enhances the production of granulocyte-macrophage colony-stimulating factor via protein kinase Calpha and extracellular signal-regulated kinase in human keratinocytes. J Invest Dermatol 122:863-872 (Pubitemid 38580986)
208. Kanda N, Watanabe S (2007) Histamine enhances the production of human beta-defensin-2 in human keratinocytes. Am J Physiol Cell Physiol 293:C1916-C1923 (Pubitemid 350255069)
209. Kaneko K, Travers JB, Matsui MS, Young AR, Norval M, Walker SL (2009) cis-Urocanic acid stimulates primary human keratinocytes independently of serotonin or platelet-activating factor receptors. J Invest Dermatol 129:2567-2573
210. Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S, Starowicz K, Steuder R, Schlicker E, Cravatt B, Mechoulam R, Buettner R, Werner S, Di Marzo V, Tuting T, Zimmer A (2007) Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316:1494-1497 (Pubitemid 46906619)
211. Karst M, Wippermann S, Ahrens J (2010) Role of cannabinoids in the treatment of pain and (painful) spasticity. Drugs 70:2409-2438
212. Karteris E, Grammatopoulos D, Dai Y, Olah KB, Ghobara TB, Easton A, Hillhouse EW (1998) The human placenta and fetal membranes express the corticotropin-releasing hormone receptor 1alpha (CRH-1alpha) and the CRH-C variant receptor. J Clin Endocrinol Metab 83:1376-1379 (Pubitemid 28496422)
213. Karteris E, Markovic D, Chen J, Hillhouse EW, Grammatopoulos DK (2011) Identification of a novel corticotropin-releasing hormone type 1beta-like receptor variant lacking Exon 13 in human pregnant myometrium regulated by estradiol-17beta and progesterone. Endocrinology 151:4959-4968
214. Kasumagic-Halilovic E, Prohic A, Begovic B, Ovcina-Kurtovic N (2011) Association between vitiligo and thyroid autoimmunity. J Thyroid Res 2011:938257
215. Kauser S, Thody AJ, Schallreuter KU, Gummer CL, Tobin DJ (2004) beta-Endorphin as a regulator of human hair follicle melanocyte biology. J Invest Dermatol 123:184-195 (Pubitemid 38833480)
216. Kauser S, Slominski A, Wei ET, Tobin DJ (2006)Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides. FASEB J 20:882-895 (Pubitemid 44961991)
217. Keen SB, Yelverton CB, Rapp SR, Feldman SR (2008) UV light abuse as a substance-related disorder: clinical implications. Arch Dermatol 144:1047-1048
218. Khalil Z, Helme RD (1990) Serotonin modulates substance P-induced plasma extravasation and vasodilatation in rat skin by an action through capsaicin-sensitive primary afferent nerves. Brain Res 527:292-298 (Pubitemid 20290609)
219. Khalil EM, De Angelis J, Cole PA (1998) Indoleamine analogs as probes of the substrate selectivity and catalytic mechanism of serotonin N-acetyltransferase. J Biol Chem 273:30321-30327 (Pubitemid 28545501)
220. Kim NH, Lee AY (2010) Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival. Exp Dermatol 19:1073-1079
221. Kircik L (2010) A nonsteroidal lamellar matrix cream containing palmitoylethanolamide for the treatment of atopic dermatitis. J Drugs Dermatol 9:334-338
222. Klein DC (2004) The 2004 Aschoff/Pittendrigh lecture: theory of the origin of the pineal gland-a tale of conflict and resolution. J Biol Rhythms 19:264-279 (Pubitemid 38943762)
223. Klein DC (2007) Arylalkylamine N-acetyltransferase: "the Timezyme". J Biol Chem 282:4233-4237
224. Ko MC, Husbands SM (2009) Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates. J Pharmacol Exp Ther 328:193-200
225. Kobayashi H, Kromminga A, Dunlop TW, Tychsen B, Conrad F, Suzuki N, Memezawa A, Bettermann A, Aiba S, Carlberg C, Paus R (2005) A role of melatonin in neuroectodermalmesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors. FASEB J 19:1710-1712 (Pubitemid 41429538)
226. Koizumi H, Ohkawara A (1999) H2 histamine receptor-mediated increase in intracellular Ca2+ in cultured human keratinocytes. J Dermatol Sci 21:127-132 (Pubitemid 29401979)
227. Koizumi H, Shimizu T, Nishino H, Ohkawara A (1998) Cis-urocanic acid attenuates histamine receptor-mediated activation of adenylate cyclase and increase in intracellular Ca2+. Arch Dermatol Res 290:264-269 (Pubitemid 28301553)
228. Kono M, Nagata H, Umemura S, Kawana S, Osamura RY (2001) In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. FASEB J 15:2297-2299
229. Kopin IJ, Pare CM, Axelrod J, Weissbach H (1961) The fate of melatonin in animals. J Biol Chem 236:3072-3075
230. Kourosh AS, Harrington CR, Adinoff B (2010) Tanning as a behavioral addiction. Am J Drug Alcohol Abuse 36:284-290
231. Kraetke O, Wiesner B, Eichhorst J, Furkert J, Bienert M, Beyermann M (2005) Dimerization of corticotropin-releasing factor receptor type 1 is not coupled to ligand binding. J Recept Signal Transduct Res 25:251-276 (Pubitemid 43068279)
232. Kripke ML (1994) Ultraviolet radiation and immunology: something new under the sun-presidential address. Cancer Res 54:6102-6105
233. Kupczyk P, Reich A, Szepietowski JC (2009) Cannabinoid system in the skin-a possible target for future therapies in dermatology. Exp Dermatol 18:669-679
234. Kurzen H, Schallreuter KU (2004) Novel aspects in cutaneous biology of acetylcholine synthesis and acetylcholine receptors. Exp Dermatol 13(Suppl 4):27-30 (Pubitemid 39654438)
235. Labrie F, Luu-The V, Labrie C, Pelletier G, El-Alfy M (2000) Intracrinology and the skin. Hormone Res 54:218-229 (Pubitemid 34701727)
236. Labrie F, Luu-The V, Labrie C, Belanger A, Simard J, Lin SX, Pelletier G (2003) Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 24:152-182 (Pubitemid 36515283)
237. Lagerstrom MC, Schioth HB (2008) Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 7:339-357
238. Lands AM, Arnold A, Mcauliff JP, Luduena FP, Brown TG Jr (1967) Differentiation of receptor systems activated by sympathomimetic amines. Nature 214:597-598
239. Lassalle MW, Igarashi S, Sasaki M, Wakamatsu K, Ito S, Horikoshi T (2003) Effects of melanogenesis-inducing nitric oxide and histamine on the production of eumelanin and pheomelanin in cultured human melanocytes. Pigment Cell Res 16:81-84 (Pubitemid 36596698)
240. Lee KS, Lee WS, Suh SI, Kim SP, Lee SR, Ryoo YW, Kim BC (2003) Melatonin reduces ultraviolet-B induced cell damages and polyamine levels in human skin fibroblasts in culture. Exp Mol Med 35:263-268
241. Lefebvre H, Compagnon P, Contesse V, Delarue C, Thuillez C, Vaudry H, Kuhn JM (2001) Production and metabolism of serotonin (5-HT) by the human adrenal cortex: paracrine stimulation of aldosterone secretion by 5-HT. J Clin Endocrinol Metab 86:5001-5007 (Pubitemid 33020556)
242. Legat FJ, Wolf P (2009) Cutaneous sensory nerves: mediators of phototherapeutic effects? Front Biosci 14:4921-4931
243. Lehmann B, Querings K, Reichrath J (2004) Vitamin D and skin: new aspects for dermatology. Exp Dermatol 13(Suppl 4):11-15 (Pubitemid 39654435)
244. Levins PC, Carr DB, Fisher JE, Momtaz K, Parrish JA (1983) Plasma beta-endorphin and betalipoprotein response to ultraviolet radiation. Lancet 2:166 (Pubitemid 13067455)
245. Li W, Chen J, Janjetovic Z, Kim TK, Sweatman T, Lu Y, Zjawiony J, Tuckey RC, Miller D, Slominski A (2010) Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity. Steroids 75:926-935
246. Ling P, Ngo K, Nguyen S, Thurmond RL, Edwards JP, Karlsson L, Fung-Leung WP (2004) Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol 142:161-171 (Pubitemid 38698205)
247. Lonne-Rahm SB, Rickberg H, El-Nour H, Marin P, Azmitia EC, Nordlind K (2008) Neuroimmune mechanisms in patients with atopic dermatitis during chronic stress. J Eur Acad Dermatol Venereol 22:11-18
248. Lu X, Farmer P, Rubin J, Nanes MS (2004) Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1, 25-dihydroxyvitamin D3-stimulated transcription. J Cell Biochem 92:833-848 (Pubitemid 44264272)
249. Luchetti F, Canonico B, Betti M, Arcangeletti M, Pilolli F, Piroddi M, Canesi L, Papa S, Galli F (2010) Melatonin signaling and cell protection function. FASEB J 24:3603-3624
250. Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T (2011) Epigenetics in alternative pre-mRNA splicing. Cell 144:16-26
251. Ma X, Idle JR, Krausz KW, Gonzalez FJ (2005) Metabolism of melatonin by human cytochromes p450. Drug Metab Dispos 33:489-494 (Pubitemid 40393190)
252. Ma X, Chen C, Krausz KW, Idle JR, Gonzalez FJ (2008) A metabolomic perspective of melatonin metabolism in the mouse. Endocrinology 149:1869-1879 (Pubitemid 351468324)
253. Maccarrone M, Di Rienzo M, Battista N, Gasperi V, Guerrieri P, Rossi A, Finazzi-Agro A (2003) The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem 278:33896-33903 (Pubitemid 37553223)
254. Maharaj DS, Anoopkumar-Dukie S, Glass BD, Antunes EM, Lack B, Walker RB, Daya S (2002) The identification of the UV degradants of melatonin and their ability to scavenge free radicals. J Pineal Res 32:257-261 (Pubitemid 34478288)
255. Mammone T, Marenus K, Maes D, Lockshin RA (1998) The induction of terminal differentiation markers by the cAMP pathway in human HaCaT keratinocytes. Skin Pharmacol Appl Skin Physiol 11:152-160 (Pubitemid 28466446)
256. Marcos J, Guo LW, Wilson WK, Porter FD, Shackleton C (2004) The implications of 7-dehydrosterol-7-reductase deficiency (Smith-Lemli-Opitz syndrome) to neurosteroid production. Steroids 69:51-60 (Pubitemid 38050302)
257. Markovic D, Grammatopoulos DK (2009) Focus on the splicing of secretin GPCRs transmembrane-domain 7. Trends Biochem Sci 34:443-452
258. Markovic D, Lehnert H, Levine MA, Grammatopoulos DK (2008) Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d. Mol Endocrinol 22:2505-2519
259. Martinez-Iglesias O, Garcia-Silva S, Tenbaum SP, Regadera J, Larcher F, Paramio JM, Vennstrom B, Aranda A (2009) Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis. Cancer Res 69:501-509
260. Martin-Ezquerra G, Man MQ, Hupe M, Rodriguez-Martin M, Youm JK, Trullas C, Mackenzie DS, Radek KA, Holleran WM, Elias PM (2011) Psychological stress regulates antimicrobial peptide expression by both glucocorticoid and beta-adrenergic mechanisms. Eur J Dermatol 21 (Suppl 2):48-51
261. Matsuda M, Imaoka T, Vomachka AJ, Gudelsky GA, Hou Z, Mistry M, Bailey JP, Nieport KM, Walther DJ, Bader M, Horseman ND (2004) Serotonin regulates mammary gland development via an autocrine-paracrine loop. Dev Cell 6:193-203 (Pubitemid 38195217)
262. Maurer M, Opitz M, Henz BM, Paus R (1997) The mast cell products histamine and serotonin stimulate and TNF-alpha inhibits the proliferation of murine epidermal keratinocytes in situ. J Dermatol Sci 16:79-84 (Pubitemid 28004778)
263. Maurice P, Daulat AM, Turecek R, Ivankova-Susankova K, Zamponi F, Kamal M, Clement N, Guillaume JL, Bettler B, Gales C, Delagrange P, Jockers R (2010) Molecular organization and dynamics of the melatonin MT receptor/RGS20/G(i) protein complex reveal asymmetry of receptor dimers for RGS and G(i) coupling. EMBO J 29:3646-3659
264. Mazurkiewicz JE, Corliss D, Slominski A (2000) Spatiotemporal expression, distribution, and processing of POMC and POMC-derived peptides in murine skin. J Histochem Cytochem 48:905-914 (Pubitemid 30421554)
265. Mazzoni A, Leifer CA, Mullen GE, Kennedy MN, Klinman DM, Segal DM (2003) Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells. J Immunol 170:2269-2273 (Pubitemid 36245610)
266. Memoli S, Napolitano A, D'ischia M, Misuraca G, Palumbo A, Prota G (1997) Diffusible melaninrelated metabolites are potent inhibitors of lipid peroxidation. Biochim Biophys Acta 1346:61-68 (Pubitemid 27220310)
267. Mikhailova MV, Mayeux PR, Jurkevich A, Kuenzel WJ, Madison F, Periasamy A, Chen Y, Cornett LE (2007) Heterooligomerization between vasotocin and corticotropin-releasing hormone (CRH) receptors augments CRH-stimulated 30, 50-cyclic adenosine monophosphate production. Mol Endocrinol 21:2178-2188 (Pubitemid 47347380)
268. Milewich L, Kaimal V, Shaw CB, Sontheimer RD (1986) Epidermal keratinocytes: a source of 5 alpha-dihydrotestosterone production in human skin. J Clin Endocrinol Metab 62:739-746 (Pubitemid 16138148)
269. Milewich L, Shaw CE, Doody KM, Rainey WE, Mason JI, Carr BR (1991) 3 beta-Hydroxysteroid dehydrogenase activity in glandular and extraglandular human fetal tissues. J Clin Endocrinol Metab 73:1134-1140 (Pubitemid 21901159)
270. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189-225 (Pubitemid 28070979)
271. Mockus SM, Vrana KE (1998) Advances in the molecular characterization of tryptophan hydroxylase. J Mol Neurosci 10:163-179 (Pubitemid 28427885)
272. Moniaga CS, Egawa G, Doi H, Miyachi Y, Kabashima K (2011) Histamine modulates the responsiveness of keratinocytes to IL-17 and TNF-alpha through the H1-receptor. J Dermatol Sci 61:79-81
273. Mossner R, Lesch KP (1998) Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun 12:249-271 (Pubitemid 29224829)
274. Mousa SA, Cheppudira BP, Shaqura M, Fischer O, Hofmann J, Hellweg R, Schafer M (2007) Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain 130:502-513 (Pubitemid 46181103)
275. Musso NR, Brenci S, Indiveri F, Lotti G (1997) L-tyrosine and nicotine induce synthesis of LDopa and norepinephrine in human lymphocytes. J Neuroimmunol 74:117-120 (Pubitemid 27128985)
276. Nag K, Sultana N, Kato A, Hirose S (2007) Headless splice variant acting as dominant negative calcitonin receptor. Biochem Biophys Res Commun 362:1037-1043 (Pubitemid 47390679)
277. Nakano K, Yamaoka K, Hanami K, Saito K, Sasaguri Y, Yanagihara N, Tanaka S, Katsuki I, Matsushita S, Tanaka Y (2011) Dopamine induces IL-6-dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis/SCID mouse chimera model. J Immunol 186:3745-3752
278. Napolitano A, Memoli S, Nappi AJ, D'ischia M, Prota G (1996) 5-S-cysteinyldopa, a diffusible product of melanocyte activity, is an efficient inhibitor of hydroxylation/oxidation reactions induced by the Fenton system. Biochim Biophys Acta 1291:75-82 (Pubitemid 26284328)
279. Nelson M, Foxwell AR, Tyrer P, Dean RT (2007) Protein-bound 3, 4-dihydroxy-phenylanine (DOPA), a redox-active product of protein oxidation, as a trigger for antioxidant defences. Int J Biochem Cell Biol 39:879-889 (Pubitemid 46575316)
280. Nguyen VT, Ndoye A, Grando SA (2000) Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. Am J Pathol 157:1377-1391
281. Nguyen VT, Arredondo J, Chernyavsky AI, Kitajima Y, Grando SA (2003) Keratinocyte acetylcholine receptors regulate cell adhesion. Life Sci 72:2081-2085 (Pubitemid 36298951)
282. Nguyen MN, Slominski A, Li W, Ng YR, Tuckey RC (2009) Metabolism of vitamin D2 to 17, 20, 24-trihydroxyvitamin D2 by cytochrome p450scc (CYP11A1). Drug Metab Dispos 37:761-767
283. Nissen JB, Kragballe K (1997) Enkephalins modulate differentiation of normal human keratinocytes in vitro. Exp Dermatol 6:222-229 (Pubitemid 27421663)
284. Nixon AJ, Choy VJ, Parry AL, Pearson AJ (1993) Fiber growth initiation in hair follicles of goats treated with melatonin. J Exp Zool 267:47-56
285. Nolan BV, Feldman SR (2009) Ultraviolet tanning addiction. Dermatol Clin 27:109-112
286. Nolan BV, Taylor SL, Liguori A, Feldman SR (2009) Tanning as an addictive behavior: a literature review. Photodermatol Photoimmunol Photomed 25:12-19
287. Nordlind K, Azmitia EC, Slominski A (2008) The skin as a mirror of the soul: exploring the possible roles of serotonin. Exp Dermatol 17:301-311 (Pubitemid 351338673)
288. Nosjean O, Ferro M, Coge F, Beauverger P, Henlin JM, Lefoulon F, Fauchere JL, Delagrange P, Canet E, Boutin JA (2000) Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 275:31311-31317
289. Ohnemus U, Uenalan M, Inzunza J, Gustafsson JA, Paus R (2006) The hair follicle as an estrogen target al.nd source. Endocr Rev 27:677-706 (Pubitemid 44592463)
290. Oka S, Wakui J, Ikeda S, Yanagimoto S, Kishimoto S, Gokoh M, Nasui M, Sugiura T (2006) Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. J Immunol 177:8796-8805 (Pubitemid 44893846)
291. Okayama Y, Church MK (1992) Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. Int Arch Allergy Immunol 97:216-225
292. Owens MJ, Nemeroff CB (1991) Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-473
293. Pacher P, Mechoulam R (2011) Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res 50:193-211
294. Page-Mccaw PS, Chung SC, Muto A, Roeser T, Staub W, Finger-Baier KC, Korenbrot JI, Baier H (2004) Retinal network adaptation to bright light requires tyrosinase. Nat Neurosci 7:1329-1336 (Pubitemid 41057755)
295. Pandi-Perumal SR, Srinivasan V, Maestroni GJ, Cardinali DP, Poeggeler B, Hardeland R (2006) Melatonin: nature's most versatile biological signal? FEBS J 273:2813-2838
296. Paradisi A, Pasquariello N, Barcaroli D, MaccarroneM(2008) Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner. J Biol Chem 283:6005-6012
297. Park HY, Kosmadaki M, Yaar M, Gilchrest BA (2009) Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci 66:1493-1506
298. Patel T, Yosipovitch G (2010) Therapy of pruritus. Expert Opin Pharmacother 11:1673-1682
299. Pattwell DM, Lynaugh KJ, Watson RE, Paus R (2010) HaCaT keratinocytes express functional receptors for thyroid-stimulating hormone. J Dermatol Sci 59:52-55
300. Payne AH, Hales DB (2004) Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 25:947-970 (Pubitemid 39657774)
301. Perrin MH, ValeWW(1999) Corticotropin releasing factor receptors and their ligand family. Ann NY Acad Sci 885:312-328
302. Perrin MH, Digruccio MR, Koerber SC, Rivier JE, Kunitake KS, Bain DL, Fischer WH, ValeWW (2003) A soluble form of the first extracellular domain of mouse type 2beta corticotropinreleasing factor receptor reveals differential ligand specificity. J Biol Chem 278:15595-15600 (Pubitemid 36799668)
303. Pinczewski J, Slominski A (2010) The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms. Exp Dermatol 19:860-864
304. Pisarchik A, Slominski AT (2001) Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J 15:2754-2756
305. Pisarchik A, Slominski A (2002) Corticotropin releasing factor receptor type 1: molecular cloning and investigation of alternative splicing in the hamster skin. J Invest Dermatol 118:1065-1072 (Pubitemid 34639187)
306. Pisarchik A, Slominski A (2004) Molecular and functional characterization of novel CRFR1 isoforms from the skin. Eur J Biochem 271:2821-2830 (Pubitemid 38869983)
307. Pisarchik A, Wortsman J, Slominski A (2004) A novel microarray to evaluate stress-related genes in skin: effect of ultraviolet light radiation. Gene 341:199-207 (Pubitemid 39335895)
308. Poeggeler B, Knuever J, Gaspar E, Biro T, Klinger M, Bodo E, Wiesner RJ, Wenzel BE, Paus R (2010) Thyrotropin powers human mitochondria. FASEB J 24:1525-1531
309. Polakiewicz RD, Behar OZ, Comb MJ, Rosen H (1992) Regulation of proenkephalin expression in cultured skin mesenchymal cells. Mol Endocrinol 6:399-408
310. Polymeropoulos MH, Torres R, Yanovski JA, Chandrasekharappa SC, Ledbetter DH (1995) The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22. Genomics 28:123-124
311. Pozo D, Garcia-Maurino S, Guerrero JM, Calvo JR (2004) mRNA expression of nuclear receptor RZR/RORalpha, melatonin membrane receptor MT, and hydroxindole-O-methyltransferase in different populations of human immune cells. J Pineal Res 37:48-54 (Pubitemid 38969020)
312. Pritchard LE, White A (2007) Neuropeptide processing and its impact on melanocortin pathways. Endocrinology 148:4201-4207 (Pubitemid 47295669)
313. Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G et al (2009) Variants in MTNR1B influence fasting glucose levels. Nat Genet 41:77-81
314. Przewlocki R (2004) Opioid abuse and brain gene expression. Eur J Pharmacol 500:331-349 (Pubitemid 39304019)
315. Przewlocki R, Przewlocka B (2005) Opioids in neuropathic pain. Curr Pharm Des 11:3013-3025 (Pubitemid 41158089)
316. Pucci M, Pirazzi V, Pasquariello N, Maccarrone M (2011) Endocannabinoid signaling and epidermal differentiation. Eur J Dermatol Suppl 2:29-34
317. Pullar CE, Isseroff RR (2006) The beta 2-adrenergic receptor activates pro-migratory and proproliferative pathways in dermal fibroblasts via divergent mechanisms. J Cell Sci 119:592-602
318. Pullar CE, Isseroff RR, Nuccitelli R (2001) Cyclic AMP-dependent protein kinase A plays a role in the directed migration of human keratinocytes in a DC electric field. Cell Motil Cytoskeleton 50:207-217 (Pubitemid 34024378)
319. Pullar CE, Manabat-Hidalgo CG, Bolaji RS, Isseroff RR (2008) beta-Adrenergic receptor modulation of wound repair. Pharmacol Res 58:158-164
320. Quevedo ME, Slominski A, Pinto W, Wei E, Wortsman J (2001) Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In Vitro Cell Dev Biol Anim 37:50-54 (Pubitemid 32245954)
321. Rahn EJ, Hohmann AG (2009) Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside. Neurotherapeutics 6:713-737
322. Randall VA, Thornton MJ, Messenger AG, Hibberts NA, Loudon AS, Brinklow BR (1993) Hormones and hair growth: variations in androgen receptor content of dermal papilla cells cultured from human and red deer (Cervus elaphus) hair follicles. J Invest Dermatol 101:114S-120S (Pubitemid 23216894)
323. Rasul A, El-Nour H, Blakely RD, Lonne-Rahm SB, Forsberg J, Johansson B, Theodorsson E, Nordlind K (2011) Effect of chronic mild stress on serotonergic markers in the skin and brain of the NC/Nga atopic-like mouse strain. Arch Dermatol Res 303:625-633
324. Reich A, Wojcik-Maciejewicz A, Slominski AT (2010) Stress and the skin. G Ital Dermatol Venereol 145:213-219
325. Reichrath J (2007) Vitamin D and the skin: an ancient friend, revisited. Exp Dermatol 16:618-625 (Pubitemid 46958568)
326. Reiter RJ (1991) Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 12:151-180
327. Reiter RJ, Tan DX, Pilar Terron M, Flores LJ, Czarnocki Z (2007) Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 54:1-9 (Pubitemid 46481811)
328. Ricketts ML, Verhaeg JM, Bujalska I, Howie AJ, Rainey WE, Stewart PM (1998) Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Met 83:1325-1335 (Pubitemid 28496416)
329. Rogoff D, Gomez-Sanchez CE, Foecking MF, Wortsman J, Slominski A (2001) Steroidogenesis in the human skin: 21-hydroxylation in cultured keratinocytes. J Steroid Biochem Mol Biol 78:77-81 (Pubitemid 32786789)
330. Roloff B, Fechner K, Slominski A, Furkert J, Botchkarev VA, Bulfone-Paus S, Zipper J, Krause E, Paus R (1998) Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. FASEB J 12:287-297 (Pubitemid 28106776)
331. Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M (2006) Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev 86:1309-1379 (Pubitemid 44523706)
332. Roseboom PH, Namboodiri MA, Zimonjic DB, Popescu NC, Rodriguez IR, Gastel JA, Klein DC (1998) Natural melatonin 'knockdown' in C57BL/6J mice: rare mechanism truncates serotonin N-acetyltransferase. Brain Res Mol Brain Res 63:189-197 (Pubitemid 28559101)
333. Ross PC, Kostas CM, Ramabhadran TV (1994) A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology. Biochem Biophys Res Commun 205:1836-1842
334. Rousseau K, Kauser S, Pritchard LE, Warhurst A, Oliver RL, Slominski A, Wei ET, Thody AJ, Tobin DJ, White A (2007) Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis. FASEB J 21:1844-1856 (Pubitemid 46855630)
335. Ryoo YW, Suh SI, Mun KC, Kim BC, Lee KS (2001) The effects of the melatonin on ultraviolet-B irradiated cultured dermal fibroblasts. J Dermatol Sci 27:162-169 (Pubitemid 32964688)
336. Safer JD, Persons K, Holick MF (2009) A thyroid hormone deiodinase inhibitor can decrease cutaneous cell proliferation in vitro. Thyroid 19:181-185
337. Sagar DR, Staniaszek LE, Okine BN, Woodhams S, Norris LM, Pearson RG, Garle MJ, Alexander SP, Bennett AJ, Barrett DA, Kendall DA, Scammell BE, Chapman V (2010) Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain. Arthritis Rheum 62:3666-3676
338. Saha B, Mondal AC, Basu S, Dasgupta PS (2001) Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysis. Int Immunopharmacol 1:1363-1374 (Pubitemid 32522988)
339. Salemi S, Aeschlimann A, Reisch N, Jungel A, Gay RE, Heppner FL, Michel BA, Gay S, Sprott H (2005) Detection of kappa and delta opioid receptors in skin-outside the nervous system. Biochem Biophys Res Commun 338:1012-1017 (Pubitemid 41597741)
340. Salim S, Ali SA (2011) Vertebrate melanophores as potential model for drug discovery and development: a review. Cell Mol Biol Lett 16:162-200
341. Sanchez AJ, Garcia-Merino A (2012) Neuroprotective agents: Cannabinoids. Clin Immunol 142:57-67
342. Scarparo AC, Visconti MA, De Oliveira AR, Castrucci AM (2000) Adrenoceptors in normal and malignant human melanocytes. Arch Dermatol Res 292:265-267 (Pubitemid 30265053)
343. Schallreuter KU, Wood JM, Lemke R, Lepoole C, Das P, Westerhof W, Pittelkow MR, Thody AJ (1992) Production of catecholamines in the human epidermis. Biochem Biophys Res Comm 189:72-78 (Pubitemid 23030010)
344. Schallreuter KU, Wood JM, Pittelkow MR, Swanson NN, Steinkraus V (1993) Increased in vitro expression of beta 2-adrenoceptors in differentiating lesional keratinocytes of vitiligo patients. Arch Dermatol Res 285:216-220 (Pubitemid 23210106)
345. Schallreuter KU, Wood JM, Pittelkow MR, Gutlich M, Lemke KR, Rodl W, Swanson NN, Hitzemann K, Ziegler I (1994) Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 263:1444-1446 (Pubitemid 24137834)
346. Schallreuter KU, Lemke KR, Pittelkow MR, Wood JM, Korner C, Malik R (1995) Catecholamines in human keratinocyte differentiation. J Invest Dermatol 104:953-957
347. Schallreuter KU, Korner C, Pittelkow MR, Swanson NN, Gardner ML (1996) The induction of the alpha-1-adrenoceptor signal transduction system on human melanocytes. Exp Dermatol 5:20-23 (Pubitemid 26040618)
348. Schallreuter KU, Pittelkow MR, Swanson NN, Beazley WD, Korner C, Ehrke C, Buttner G (1997) Altered catecholamine synthesis and degradation in the epidermis of patients with atopic eczema. Arch Dermatol Res 289:663-666 (Pubitemid 28014195)
349. Schallreuter KU, Beazley WD, Hibberts NA, Tobin DJ, Paus R, Wood JM (1998) Pterins in human hair follicle cells and in the synchronized murine hair cycle. J Invest Dermatol 111:545-550 (Pubitemid 28452311)
350. Schallreuter KU, Bahadoran P, Picardo M, Slominski A, Elassiuty YE, Kemp EH, Giachino C, Liu JB, Luiten RM, Lambe T, Le Poole IC, Dammak I, Onay H, Zmijewski MA, Dell'anna ML, Zeegers MP, Cornall RJ, Paus R, Ortonne JP, Westerhof W (2008a) Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol 17:139-140, discussion 141-160
351. Schallreuter KU, Kothari S, Chavan B, Spencer JD (2008b) Regulation of melanogenesis-controversies and new concepts. Exp Dermatol 17:395-404 (Pubitemid 351513953)
352. Schmelz M (2010) Itch and pain. Neurosci Biobehav Rev 34:171-176
353. Schmelz M, Paus R (2007) Opioids and the skin: "itchy" perspectives beyond analgesia and abuse. J Invest Dermatol 127:1287-1289 (Pubitemid 46762964)
354. Schmid B, Blomeyer D, Treutlein J, Zimmermann US, Buchmann AF, Schmidt MH, Esser G, Rietschel M, Banaschewski T, Schumann G, Laucht M (2009) Interacting effects of CRHR1 gene and stressful life events on drinking initiation and progression among 19-year-olds. Int J Neuropsychopharmacol 3:1-12
355. Scislowski PW, Slominski A, Bomirski A (1984) Biochemical characterization of three hamster melanoma variants-II. Glycolysis and oxygen consumption. Int J Biochem 16:327-331 (Pubitemid 14129988)
356. Scislowski PW, Slominski A, Bomirski A, Zydowo M (1985) Metabolic characterization of three hamster melanoma variants. Neoplasma 32:593-598 (Pubitemid 16219077)
357. Seck T, Pellegrini M, Florea AM, Grignoux V, Baron R, Mierke DF, HorneWC(2005) The delta e13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominantnegative effects on receptor surface expression and signaling. Mol Endocrinol 19:2132-2144 (Pubitemid 41124207)
358. Seever K, Hardeland R (2008) Novel pathway for N(1)-acetyl-5- methoxykynuramine: UVBinduced liberation of carbon monoxide from precursor N(1)-acetyl-N(2)-formyl-5-methoxykynuramine. J Pineal Res 44:450-455 (Pubitemid 351533530)
359. Seiffert K, Hosoi J, Torii H, Ozawa H, Ding W, Campton K, Wagner JA, Granstein RD (2002) Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J Immunol 168:6128-6135 (Pubitemid 34620030)
360. Selye H (1936) A syndrome produced by various noxious agents. Nat London 138:32-33
361. Semak I, Korik E, Naumova M, Wortsman J, Slominski A (2004) Serotonin metabolism in rat skin: characterization by liquid chromatography-mass spectrometry. Arch Biochem Biophys 421:61-66 (Pubitemid 37543496)
362. Semak I, Naumova M, Korik E, Terekhovich V, Wortsman J, Slominski A (2005) A novel metabolic pathway of melatonin: oxidation by cytochrome C. Biochemistry 44:9300-9307 (Pubitemid 40934380)
363. Semak I, Korik E, Antonova M, Wortsman J, Slominski A (2008) Metabolism of melatonin by cytochrome P450s in rat liver mitochondria and microsomes. J Pineal Res 45:515-523
364. Seuwen K, Pouysségur J (1990) Serotonin as a growth factor. Biochem Pharmacol 39(6):985-990 (Pubitemid 20103670)
365. Seyle H (1976) The stress of life. McGraw-Hill Book Company, New York, NY
366. Shackleton CH, Roitman E, Kelley R (1999) Neonatal urinary steroids in Smith-Lemli-Opitz syndrome associated with 7-dehydrocholesterol reductase deficiency. Steroids 64:481-490 (Pubitemid 29353116)
367. Shackleton C, Roitman E, Guo LW, Wilson WK, Porter FD (2002) Identification of 7(8) and 8(9) unsaturated adrenal steroid metabolites produced by patients with 7-dehydrosterol-delta7-reductase deficiency (Smith-Lemli-Opitz syndrome). J Steroid Bioche Mol Biol 82:225-232 (Pubitemid 35435371)
368. Sharpley CF, Kauter KG, Mcfarlane JR (2009) An initial exploration of in vivo hair cortisol responses to a brief pain stressor: latency, localization and independence effects. Physiol Res 58:757-761
369. Shinoda S, Kameyoshi Y, Hide M, Morita E, Yamamoto S (1998) Histamine enhances UVBinduced IL-6 production by human keratinocytes. Arch Dermatol Res 290:429-434 (Pubitemid 28431852)
370. Sidler D, Renzulli P, Schnoz C, Berger B, Schneider-Jakob S, Fluck C, Inderbitzin D, Corazza N, Candinas D, Brunner T (2011) Colon cancer cells produce immunoregulatory glucocorticoids. Oncogene 30:2411-2419
371. Siemionow M, Gharb BB, Rampazzo A (2011) The face as a sensory organ. Plast Reconstr Surg 127:652-662
372. Sikand P, Dong X, Lamotte RH (2011) BAM8-22 peptide produces itch and nociceptive sensations in humans independent of histamine release. J Neurosci 31:7563-7567
373. Simard J, Couet J, Durocher F, Labrie Y, Sanchez R, Breton N, Turgeon C, Labrie F (1993) Structure and tissue-specific expression of a novel member of the rat 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) family. The exclusive 3 beta-HSD gene expression in the skin. J Biol Chem 268:19659-19668 (Pubitemid 23270756)
374. Simard J, Ricketts ML, Gingras S, Soucy P, Feltus FA, Melner MH (2005) Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocrine Rev 26:525-582 (Pubitemid 41014265)
375. Sivamani RK, Lam ST, Isseroff RR (2007) Beta adrenergic receptors in keratinocytes. Dermatol Clin 25:643-653 (Pubitemid 47446084)
376. Sivamani RK, Porter SM, Isseroff RR (2009) An epinephrine-dependent mechanism for the control of UV-induced pigmentation. J Invest Dermatol 129:784-787
377. Skobowiat C, Dowdy JC, Sayre RM, Tuckey RC, Slominski AT (2011) Cutaneous hypothalamic pituitary adrenal (HPA) axis homologue-regulation by ultraviolet radiation. Am J Physiol Endocrinol Metab 301:E484-E493
378. Slominski A (1991) POMC gene expression in mouse and hamster melanoma cells. FEBS Lett 291:165-168
379. Slominski A (2003) Beta-endorphin/mu-opiate receptor system in the skin. J Invest Dermatol. 120: xii-xiii
380. Slominski A (2005) Neuroendocrine system of the skin. Dermatology 211:199-208 (Pubitemid 41415859)
381. Slominski A (2007) A nervous breakdown in the skin: stress and the epidermal barrier. J Clin Invest 117:3166-3169 (Pubitemid 350096970)
382. Slominski A (2009a) Are suberythemal doses of ultraviolet B good for your skin? Pigment Cell Melanoma Res 22:154-155
383. Slominski A (2009b) On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders. Br J Dermatol 160:229-232
384. Slominski A (2009c) Neuroendocrine activity of the melanocyte. Exp Dermatol 18:760-763
385. Slominski A, Friedrich T (1992) L-DOPA inhibits in vitro phosphorylation of melanoma glycoproteins. Pigment Cell Res 5:396-400
386. Slominski A, Goodman-Snitkoff GG (1992) Dopa inhibits induced proliferative activity of murine and human lymphocytes. Anticancer Res 12:753-756
387. Slominski A, Paus R (1990) Are L-tyrosine and L-dopa hormone-like bioregulators. J Theor Biol 143:123-138
388. Slominski A, Paus R (1994) Towards defining receptors for L-tyrosine and L-dopa. Mol Cell Endocrinol 99:C7-C11
389. Slominski A, Pawelek J (1998) Animals under the sun: effects of ultraviolet radiation on mammalian skin. Clin Dermatol 16:503-515 (Pubitemid 29374150)
390. Slominski A, Pruski D (1993) Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp Cell Res 206:189-294
391. Slominski A, Wortsman J (2000) Neuroendocrinology of the skin. Endocrine Rev 21:457-487
392. Slominski A, Paus R, Bomirski A (1989) Hypothesis: possible role for the melatonin receptor in vitiligo: discussion paper. J R Soc Med 82:539-541 (Pubitemid 19211413)
393. Slominski A, Paus R, Mazurkiewicz J (1992) Proopiomelanocortin expression in the skin during induced hair growth in mice. Experientia 48:50-54
394. Slominski A, Paus R, Schadendorf D (1993a) Melanocytes as "sensory" and regulatory cells in the epidermis. J Theor Biol 164:103-120
395. Slominski A, Paus R, Wortsman J (1993b) On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol 93:C1-C6 (Pubitemid 23148873)
396. Slominski A, Wortsman J, Mazurkiewicz JE, Matsuoka L, Dietrich J, Lawrence K, Gorbani A, Paus R (1993c) Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med 122:658-666 (Pubitemid 2022717)
397. Slominski A, Chassalevris N, Mazurkiewicz J, Maurer M, Paus R (1994) Murine skin as a target for melatonin bioregulation. Exp Dermatol 3:45-50 (Pubitemid 24160578)
398. Slominski A, Ermak G, Hwang J, Chakraborty A, Mazurkiewicz J, Mihm M (1995) Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett 374:113-116
399. Slominski A, Baker J, Ermak G, Chakraborty A, Pawelek J (1996a) Ultraviolet B stimulates production of corticotropin releasing factor (CRF) by human melanocytes. FEBS Lett 399:175-176 (Pubitemid 27007978)
400. Slominski A, Baker J, Rosano TG, Guisti LW, Ermak G, Grande M, Gaudet SJ (1996b) Metabolism of serotonin to N-acetylserotonin, melatonin, and 5-methoxytryptamine in hamster skin culture. J Biol Chem 271:12281-12286
401. Slominski A, Ermak G, Hwang J, Mazurkiewicz J, Corliss D, Eastman A (1996c) The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin. Biochim Biophys Acta 1289:247-251 (Pubitemid 26088682)
402. Slominski A, Ermak G, Mihm MC (1996d) ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J Clin Endocrinol Metol 81:2746-2749 (Pubitemid 26240307)
403. Slominski A, Botchkareva NV, Botchkarev VA, Chakraborty A, Luger T, Uenalan M, Paus R (1998a) Hair cycle-dependent production of ACTH in mouse skin. Biochim Biophys Acta 1448:147-152 (Pubitemid 28526628)
404. Slominski A, Ermak G, Mazurkiewicz JE, Baker J, Wortsman J (1998b) Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metol 83:1020-1024 (Pubitemid 28496487)
405. Slominski A, Paus R, Mihm MC (1998c) Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. Anticancer Res 18:3709-3715 (Pubitemid 28564252)
406. Slominski A, Gomez-Sanchez C, Foecking MF, Wortsman J (1999a) Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured humanmelanoma cells. FEBS Lett 445:364-366 (Pubitemid 29333068)
407. Slominski A, Gomez-Sanchez CE, Foecking MF, Wortsman J (1999b) Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured human melanoma cells. FEBS Lett 455:364-366 (Pubitemid 29333068)
408. Slominski AT, Botchkarev V, Choudhry M, Fazal N, Fechner K, Furkert J, Krause E, Roloff B, Sayeed M, Wei E, Zbytek B, Zipper J, Wortsman J, Paus R (1999c) Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci 885:287-311
409. Slominski A, Gomez-Sanchez C, Foecking MF, Wortsman J (2000a) Active steroidogenesis in the normal rat skin. Biochim Biophys Acta 1474:1
410. Slominski A, Roloff B, Curry J, Dahiya M, Szczesniewski A, Wortsman J (2000b) The skin produces urocortin. J Clin Endocrinol Metab 85:815-823 (Pubitemid 32273673)
411. Slominski A, Wortsman J, Luger T, Paus R, Solomon S (2000c) Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 80:979-1020 (Pubitemid 30452009)
412. Slominski AT, Roloff B, Zbytek B, Wei ET, Fechner K, Curry J, Wortsman J (2000d) Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cell Dev Biol Anim 36:211-216 (Pubitemid 30193770)
413. Slominski A, Wortsman J, Pisarchik A, Zbytek B, Linton EA, Mazurkiewicz JE, Wei ET (2001) Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 15:1678-1693 (Pubitemid 32730215)
414. Slominski A, Pisarchik A, Semak I, Sweatman T, Szczesniewski A, Wortsman J (2002a) Serotoninergic system in hamster skin. J Invest Dermatol 119:934-942 (Pubitemid 35340921)
415. Slominski A, Pisarchik A, Semak I, Sweatman T, Worstman J, Szczesniewski A, Slugocki G, Mcnulty J, Kauser S, Tobin DJ (2002b) Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J 16:896-898
416. Slominski A, Semak I, Pisarchik A, Sweatman T, Szczesniewski A, Wortsman J (2002c) Conversion of L-tryptophan to serotonin and melatonin in human melanoma cells. FEBS Lett 511:102-106 (Pubitemid 34127831)
417. Slominski A, Worstman J, Foecking MF, Shackleton CH, Gomez-Sanchez CE, Szczesniewski A (2002d) Gas chromatography/mass spectrometry characterization of corticosteroid metabolism in human immortalized keratinocytes. J Invest Dermatol 118:310-315 (Pubitemid 34158486)
418. Slominski A, Wortsman J, Kohn L, Ain KB, Venkataraman GM, Pisarchik A, Chung JH, Giuliani C, Thornton M, Slugocki G, Tobin DJ (2002e) Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J Invest Dermatol 119:1449-1455 (Pubitemid 36005634)
419. Slominski A, Pisarchik A, Johansson O, Jing C, Semak I, Slugocki G, Wortsman J (2003a) Tryptophan hydroxylase expression in human skin cells. Biochim Biophys Acta 1639:80-86 (Pubitemid 38366211)
420. Slominski A, Wortsman J, Linton E, Pisarchik A, Zbytek B (2003b) The skin as a model for the immunomodulatory effects of corticotropin-releasing hormone. In: Schaefer M, Stein C (eds) Mind over matter-regulation of peripheral inflammation by the CNS. Birkhaeuser Verlag, Basel, Boston, Berlin
421. Slominski A, Pisarchik A, Semak I, Sweatman T, Wortsman J (2003c) Characterization of the serotoninergic system in the C57BL/6 mouse skin. Eur J Biochem 270:3335-3344 (Pubitemid 37011627)
422. Slominski A, Pisarchik A, Zbytek B, Tobin DJ, Kauser S, Wortsman J (2003d) Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J Cell Physiol 196:144-153 (Pubitemid 36676452)
423. Slominski A, Pisarchik A, Tobin DJ, Mazurkiewicz JE, Wortsman J (2004a) Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology 145:941-950 (Pubitemid 38183838)
424. Slominski A, Pisarchik A, Wortsman J (2004b) Expression of genes coding melatonin and serotonin receptors in rodent skin. Biochim Biophys Acta 1680:67-70 (Pubitemid 39361125)
425. Slominski A, Tobin DJ, Shibahara S, Wortsman J (2004c) Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84:1155-1228 (Pubitemid 39287950)
426. Slominski A, Zjawiony J, Wortsman J, Semak I, Stewart J, Pisarchik A, Sweatman T, Marcos J, Dunbar C, Tuckey RC (2004d) A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur J Biochem 271:4178-4188 (Pubitemid 39506746)
427. Slominski A, Fischer TW, Zmijewski MA, Wortsman J, Semak I, Zbytek B, Slominski RM, Tobin DJ (2005a) On the role of melatonin in skin physiology and pathology. Endocrine 27:137-148
428. Slominski A, Plonka PM, Pisarchik A, Smart JL, Tolle V, Wortsman J, Low MJ (2005b) Preservation of eumelanin hair pigmentation in proopiomelanocortin- deficient mice on a nonagouti (a/a) genetic background. Endocrinology 146:1245-1253 (Pubitemid 40289312)
429. Slominski A, Wortsman J, Tobin DJ (2005c) The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J 19:176-194 (Pubitemid 40189259)
430. Slominski A, Zbytek B, Semak I, Sweatman T, Wortsman J (2005d) CRH stimulates POMC activity and corticosterone production in dermal fibroblasts. J Neuroimmunol 162:97-102
431. Slominski A, Zbytek B, Szczesniewski A, Semak I, Kaminski J, Sweatman T, Wortsman J (2005e) CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab 288:E701-E706 (Pubitemid 40397204)
432. Slominski A, Semak I, Zjawiony J, Wortsman J, Li W, Szczesniewski A, Tuckey RT (2005f) The cytochrome P450scc system opens an alternate pathway of vitamin D3metabolism. FEBS J 272:480-4090
433. Slominski A, Semak I, Zjawiony J, Wortsman J, Gandy MN, Li J, Zbytek B, Li W, Tuckey RT (2005g) Enzymatic metabolism of ergosterol by cytochrome P450scc (CYP11A1) to biologically active 17a, 24-dihydroxyergosterol. Chem Biol 12:931-939 (Pubitemid 41206807)
434. Slominski A, Zbytek B, Pisarchik A, Slominski RM, Zmijewski MA, Wortsman J (2006a) CRH functions as a growth factor/cytokine in the skin. J Cell Physiol 206:780-791 (Pubitemid 43191053)
435. Slominski A, Zbytek B, Szczesniewski A, Wortsman J (2006b) Cultured human dermal fibroblasts do produce cortisol. J Invest Dermatol 126:1177-1178
436. Slominski A, Zbytek B, Zmijewski M, Slominski RM, Kauser S, Wortsman J, Tobin DJ (2006c) Corticotropin releasing hormone and the skin. Front Biosci 11:2230-2248 (Pubitemid 43832722)
437. Slominski A, Semak I, Wortsman J, Zjawiony J, Li W, Zbytek B, Tuckey T (2006d) An alternate pathway of vitamin D2 metabolism: Cytochrome P450scc (CYP11A1) mediated conversion to20-hydroxyvitamin D2 and 17, 20-dihydroxyvitamin D2. FEBS J 273:2891-2901
438. Slominski A, Wortsman J, Tuckey RC, Paus R (2007a) Differential expression of HPA axis homolog in the skin. Mol Cellular Endocrinol 265-266:143-149 (Pubitemid 46273958)
439. Slominski AT, Zmijewski MA, Pisarchik A, Wortsman J (2007b) Molecular cloning and initial characterization of African green monkey (Cercopithecus aethiops) corticotropin releasing factor receptor type 1 (CRFI) from COS-7 cells. Gene 389:154-162 (Pubitemid 46186784)
440. Slominski A, Tobin DJ, Zmijewski MA, Wortsman J, Paus R (2008a) Melatonin in the skin: synthesis, metabolism and functions. Trends Endo Metab 19:17-24
441. Slominski A, Wortsman J, Paus R, Elias PM, Tobin DJ, Feingold KR (2008b) Skin as an endocrine organ: implications for its function. Drug Discov Today Dis Mech 5:137-144
442. Slominski A, Tuckey RC, Zmijewski MA, Li W, Zjawiony J, Janjetovic Z, Zbytek B, Nguyen MN, Miller D, Chen J (2009a) Enzymatic production or chemical synthesis and uses for 5, 7-dienes and UVB conversion products thereof. In PCT/US2009/001324
443. Slominski A, Zbytek B, Slominski R (2009b) Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. Int J Cancer 124:1470-1477
444. Slominski AT, Zmijewski MA, Semak I, Sweatman T, Janjetovic Z, Li W, Zjawiony JK, Tuckey RC (2009c) Sequential metabolism of 7-dehydrocholesterol to steroidal 5, 7-dienes in adrenal glands and its biological implication in the skin. PLoS One 4:e4309
445. Slominski AT, Janjetovic Z, Fuller BE, Zmijewski MA, Tuckey RC, Nguyen MN, Sweatman T, Li W, Zjawiony J, Miller D, Chen TC, Lozanski G, Holick MF (2010) Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity. PLoS One 5:e9907
446. Slominski A, Zmijewski M, Pawelek J (2011a) L-tyrosine and L-DOPA as hormone-like regulators of melanocytes functions. Pigment Cell Melanoma Res. doi:10.1111/j.1755-148X.2011.00898.x
447. Slominski AT, Kim TK, Janjetovic Z, Tuckey RC, Bieniek R, Yue J, Li W, Chen J, Nguyen MN, Tang EK, Miller D, Chen TC, Holick M (2011b) 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells. Am J Physiol Cell Physiol 300:C526-C541
448. Slominski AT, Zmijewski MA, Zbytek B, Brozyna AA, Granese J, Pisarchik A, Szczesniewski A, Tobin DJ (2011c) Regulated proenkephalin expression in human skin and cultured skin cells. J Invest Dermatol 131:613-622
449. Slominski AT, Li W, Bhattacharya SK, Smith RA, Johnson PL, Chen J, Nelson KE, Tuckey RC, Miller D, Jiao Y, Gu W, Postlethwaite A (2011d) Vitamin D analogs 17, 20S(OH)2pD and 17, 20R(OH)2pD are noncalcemic and exhibit antifibrotic activity. J Invest Dermatol 131:1167-1169
450. Smith AI, Funder JW (1988) Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev 9:159-179
451. Spiess J, Rivier J, Rivier C, ValeW(1981) Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci USA 78:6517-6521 (Pubitemid 12179744)
452. Sreevidya CS, Khaskhely NM, Fukunaga A, Khaskina P, Ullrich SE (2008) Inhibition of photocarcinogenesis by platelet-activating factor or serotonin receptor antagonists. Cancer Res 68:3978-3984
453. Sreevidya CS, Fukunaga A, Khaskhely NM, Masaki T, Ono R, Nishigori C, Ullrich SE (2010) Agents that reverse UV-Induced immune suppression and photocarcinogenesis affect DNA repair. J Invest Dermatol 130:1428-1437
454. Srivastava BK, Soni R, Patel JZ, Joharapurkar A, Sadhwani N, Kshirsagar S, Mishra B, Takale V, Gupta S, Pandya P, Kapadnis P, Solanki M, Patel H, Mitra P, Jain MR, Patel PR (2009) Hair growth stimulator property of thienyl substituted pyrazole carboxamide derivatives as a CB1 receptor antagonist with in vivo antiobesity effect. Bioorg Med Chem Lett 19:2546-2550
455. Stander S, Gunzer M, Metze D, Luger T, Steinhoff M (2002) Localization of mu-opioid receptor 1A on sensory nerve fibers in human skin. Regul Pept 110:75-83 (Pubitemid 35435335)
456. Stander S, Schmelz M, Metze D, Luger T, Rukwied R (2005) Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci 38:177-188 (Pubitemid 40779571)
457. Steinhoff M, Bienenstock J, Schmelz M, Maurer M, Wei E, Biro T (2006) Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol 126:1705-1718 (Pubitemid 44102116)
458. Steinkraus V, Steinfath M, Korner C, Mensing H (1992) Binding of beta-adrenergic receptors in human skin. J Invest Dermatol 98:475-480
459. Steinkraus V, Mak JC, Pichlmeier U, Mensing H, Ring J, Barnes PJ (1996) Autoradiographic mapping of beta-adrenoceptors in human skin. Arch Dermatol Res 288:549-553 (Pubitemid 26280706)
460. Stenn KS, Paus R (2001) Controls of hair follicle cycling. Physiol Rev 81:449-494 (Pubitemid 32096181)
461. Su TF, Zhang LH, Peng M, Wu CH, Pan W, Tian B, Shi J, Pan HL, Li M(2011) Cannabinoid CB2 receptors contribute to upregulation of beta-endorphin in inflamed skin tissues by electroacupuncture. Mol Pain 7:98, (Epub ahead of print) PMID: 22177137
462. Sztainberg Y, Kuperman Y, Issler O, Gil S, Vaughan J, Rivier J, Vale W, Chen A (2009) A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease. FASEB J 23:2186-2196
463. Tachibana T, Nawa T (2005) Immunohistochemical reactions of receptors to met-enkephalin, VIP, substance P, and CGRP located on Merkel cells in the rat sinus hair follicle. Arch Histol Cytol 68:383-391
464. Tachibana T, Taniguchi S, Furukawa F, Miwa S, Imamura S (1990) Serotonin metabolism in the arthus reaction. J Invest Dermatol 94:120-125 (Pubitemid 20046051)
465. Tachibana T, Endoh M, Fujiwara N, Nawa T (2005) Receptors and transporter for serotonin in Merkel cell-nerve endings in the rat sinus hair follicle. An immunohistochemical study. Arch Histol Cytol 68:19-28 (Pubitemid 40570111)
466. Tagen M, Stiles L, Kalogeromitros D, Gregoriou S, Kempuraj D, Makris M, Donelan J, Vasiadi M, Staurianeas NG, Theoharides TC (2007) Skin corticotropin-releasing hormone receptor expression in psoriasis. J Invest Dermatol 127:1789-1791 (Pubitemid 46933407)
467. Takahashi H, Kinouchi M, Tamura T, Iizuka H (1996) Decreased beta 2-adrenergic receptor-mRNA and loricrin-m RNA, and increased involucrin-mRNA transcripts in psoriatic epidermis: analysis by reverse transcription-polymerase chain reaction. Br J Dermatol 134:1065-1069
468. Tan DX, Manchester LC, Burkhardt S, Sainz RM, Mayo JC, Kohen R, Shohami E, Huo YS, Hardeland R, Reiter RJ (2001) N1-acetyl-N2-formyl-5- methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 15:2294-2296
469. Tan DX, Reiter RJ, Manchester LC, Yan MT, El Sawi M, Sainz RM, Mayo JC, Kohen R, Allegra M, Hardeland R (2002) Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2:181-197
470. Taneda K, Tominaga M, Negi O, Tengara S, Kamo A, Ogawa H, Takamori K (2011) Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch. Br J Dermatol 165:277-284
471. Tang JY, Xiao TZ, Oda Y, Chang KS, Shpall E, Wu A, So PL, Hebert J, Bikle D, Epstein EH Jr (2011) Vitamin D3 inhibits hedgehog signaling and proliferation in murine basal cell carcinomas. Cancer Prev Res 4:744-751
472. Taves MD, Gomez-Sanchez CE, Soma KK (2011) Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function. Am J Physiol Endocrinol Metab 301:E11-E24
473. Tayebati SK, El-Assouad D, Ricci A, Amenta F (2002) Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. J Neuroimmunol 132:147-155 (Pubitemid 35333337)
474. Teichert AE, Elalieh H, Elias PM, Welsh J, Bikle DD (2011) Overexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null mice. J Invest Dermatol 131:2289-2297
475. Telek A, Biro T, Bodo E, Toth BI, Borbiro I, Kunos G, Paus R (2007) Inhibition of human hair follicle growth by endo-and exocannabinoids. FASEB J 21:3534-3541 (Pubitemid 350075143)
476. Theoharides TC, Cochrane DE (2004) Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 146:1-12 (Pubitemid 38032950)
477. Thiboutot D, Jabara S, Mcallister JM, Sivarajah A, Gilliland K, Cong Z, Clawson G (2003) Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J InvestDermatol 120:905-914 (Pubitemid 36702897)
478. Thorslund K, El-Nour H, Nordlind K (2009) The serotonin transporter protein is expressed in psoriasis, where it may play a role in regulating apoptosis. Arch Dermatol Res 301:449-457
479. Tian XQ, Holick MF (1999) A liposomal model that mimics the cutaneous production of vitamin D3. Studies of the mechanism of the membrane-enhanced thermal isomerization of previtamin D3 to vitamin D3. J Biol Chem 274:4174-4179
480. Tiede S, Bohm K, Meier N, Funk W, Paus R (2010) Endocrine controls of primary adult human stem cell biology: thyroid hormones stimulate keratin 15 expression, apoptosis, and differentiation in human hair follicle epithelial stem cells in situ and in vitro. Eur J Cell Biol 89:769-777
481. Tiganescu A, Walker EA, Hardy RS, Mayes AE, Stewart PM (2011) Localization, age-and sitedependent expression, and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in skin. J Invest Dermatol 131:30-36
482. Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, Salen G (1994) Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 330:107-113
483. Tobin DJ (2006) Biochemistry of human skin-our brain on the outside. Chem Soc Rev 35:52-67 (Pubitemid 43485013)
484. Tobin DJ, Kauser S (2005a) Beta-endorphin: the forgotten hair follicle melanotropin. J Investig Dermatol Symp Proc 10:212-216
485. Tobin DJ, Kauser S (2005b) Hair melanocytes as neuro-endocrine sensors-pigments for our imagination. Mol Cell Endocrinol 243:1-11 (Pubitemid 41572273)
486. Tominaga M, Ogawa H, Takamori K (2007) Possible roles of epidermal opioid systems in pruritus of atopic dermatitis. J Invest Dermatol 127:2228-2235 (Pubitemid 47258501)
487. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM (2004) 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Reviews 25:831-866 (Pubitemid 39366049)
488. Toth BI, Dobrosi N, Dajnoki A, Czifra G, Olah A, Szollosi AG, Juhasz I, Sugawara K, Paus R, Biro T (2011) Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1. J Invest Dermatol 131:1095-1104
489. Tsang AH, Chung KK (2009) Oxidative and nitrosative stress in Parkinson's disease. Biochim Biophys Acta 1792:643-650
490. Tsuji H, Okamoto K, Matsuzaka Y, Iizuka H, Tamiya G, Inoko H (2003) SLURP-2, a novel member of the human Ly-6 superfamily that is up-regulated in psoriasis vulgaris. Genomics 81:26-33 (Pubitemid 36263356)
491. Tuckey RC (2005) Progesterone synthesis by the human placenta. Placenta 26:273-281 (Pubitemid 40485864)
492. Tuckey RC, Nguyen MN, Chen J, Slominski AT, Baldisseri DM, Tieu EW, Zjawiony JK, Li W (2011) Human cytochrome P450scc (CYP11A1) catalyses epoxide formation with ergosterol. Drug Metab Dispos 40(3):436-444, (Epub ahead of print) PMID: 22106170
493. Vacchio MS, Papadopoulos V, Ashwell JD (1994) Steroid production in the thymus: implications for thymocyte selection. J Exp Med 179:1835-1846 (Pubitemid 24155664)
494. Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213:1394-1397 (Pubitemid 12243637)
495. Valencia A, Kochevar IE (2006) Ultraviolet al. induces apoptosis via reactive oxygen species in a model for Smith-Lemli-Opitz syndrome. Free Radic Biol Med 40:641-650 (Pubitemid 43170816)
496. van Beek N, Bodo E, Kromminga A, Gaspar E, Meyer K, Zmijewski MA, Slominski A, Wenzel BE, PausR (2008) Thyroid hormones directly alter human hair follicle functions: anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation. J Clin Endocrinol Metab 93:4381-4388 (Pubitemid 352789535)
497. Vaudry H, Chartrel N, Desrues L, Galas L, Kikuyama S, Mor A, Nicolas P, Tonon MC (1999) The pituitary-skin connection in amphibians. Reciprocal regulation of melanotrope cells and dermal melanocytes. Ann N Y Acad Sci 885:41-56
498. Vukelic S, Stojadinovic O, Pastar I, Rabach M, Krzyzanowska A, Lebrun E, Davis SC, Resnik S, Brem H, Tomic-Canic M (2011) Cortisol synthesis in epidermis is induced by IL-1 and tissue injury. J Biol Chem 286:10265-10275
499. Waller LA, Sarkka A, Olsbo V, Myllymaki M, Panoutsopoulou IG, Kennedy WR, Wendelschafer-Crabb G (2011) Second-order spatial analysis of epidermal nerve fibers. Stat Med 30:2827-2841
500. Wallstrom M, Sand L, Nilsson F, Hirsch JM (1999) The long-term effect of nicotine on the oral mucosa. Addiction 94:417-423 (Pubitemid 29137421)
501. Walterscheid JP, Nghiem DX, Kazimi N, Nutt LK, Mcconkey DJ, Norval M, Ullrich SE (2006) Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor. Proc Natl Acad Sci USA 103:17420-17425 (Pubitemid 44788984)
502. Wasserman D, Sokolowski M, Rozanov V, Wasserman J (2008) The CRHR1 gene: a marker for suicidality in depressed males exposed to low stress. Genes Brain Behav 7:14-19
503. Watson S (1994) Dopamine receptors. In: Watson S, Arkinstall S (eds) The G-protein linked receptor fact book. Academic Press, London, UK
504. Weedon D (2010) Weedon's skin pathology. Churchill Livingstone-Elsevier, Oxford, UK
505. Welch DA, Samuel WM, Hudson RJ (1990) Bioenergetic consequences of alopecia induced by Dermacentor albipictus (Acari: Ixodidae) on moose. J Med Entomol 27:656-660
506. Wessler I, Reinheimer T, Kilbinger H, Bittinger F, Kirkpatrick CJ, Saloga J, Knop J (2003) Increased acetylcholine levels in skin biopsies of patients with atopic dermatitis. Life Sci 72:2169-2172 (Pubitemid 36298963)
507. Wiesenberg I, Missbach M, Carlberg C (1998) The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor Neurol Neurosci 12:143-150 (Pubitemid 28368295)
508. Wiesner B, Roloff B, Fechner K, Slominski A (2003) Intracellular calcium measurements of single human skin cells after stimulation with corticotropin-releasing factor and urocortin using confocal laser scanning microscopy. J Cell Sci 116:1261-1268 (Pubitemid 36410664)
509. Wietfeld D, Heinrich N, Furkert J, Fechner K, Beyermann M, Bienert M, Berger H (2004) Regulation of the coupling to different G proteins of rat corticotropin-releasing factor receptor type 1 in human embryonic kidney 293 cells. J Biol Chem 279:38386-38394 (Pubitemid 39295988)
510. Wintzen M, Gilchrest BA (1996) Proopiomelanocortin, its derived peptides, and the skin. J Invest Dermatol 106:3-10
511. Wintzen M, Ostijn DM, Polderman MC, Le Cessie S, Burbach JP, Vermeer BJ (2001) Total body exposure to ultraviolet radiation does not influence plasma levels of immunoreactive betaendorphin in man. Photodermatol Photoimmunol Photomed 17:256-260 (Pubitemid 33072125)
512. Wu J, Lukas RJ (2011) Naturally-expressed nicotinic acetylcholine receptor subtypes. Biochem Pharmacol 82:800-807
513. Yang G, Zhang G, Pittelkow MR, Ramoni M, Tsao H (2006) Expression profiling of UVB response in melanocytes identifies a set of p53-target genes. J Invest Dermatol 126:2490-2506 (Pubitemid 44582271)
514. Yen PM (2001) Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142 (Pubitemid 32606667)
515. Yoshida M, Takahashi Y, Inoue S (2000) Histamine induces melanogenesis and morphologic changes by protein kinase A activation via H2 receptors in human normal melanocytes. J Invest Dermatol 114:334-342 (Pubitemid 30417770)
516. Yosipovitch G (2010) Chronic pruritus: a paraneoplastic sign. Dermatol Ther 23:590-596
517. Young SF, Griffante C, Aguilera G (2007) Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors. Cell Mol Neurobiol 27:439-461 (Pubitemid 46763890)
518. Yu HS, Reiter RJ (1993) Melatonin biosynthesis, physiological effects, and clinical implications. CRC Press, Boca Raton
519. Yuasa T, Ono M, Watanabe T, Takai T (2001) Lyn is essential for fcgamma receptor III-mediated systemic anaphylaxis but not for the Arthus reaction. J Exp Med 193:563-572
520. Zagon IS, Wu Y, Mclaughlin PJ (1996) The opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis. J Invest Dermatol 106:490-497 (Pubitemid 26116492)
521. Zbytek B, Slominski AT (2007) CRH mediates inflammation induced by lipopolysaccharide in human adult epidermal keratinocytes. J Invest Dermatol 127:730-732
522. Zbytek B, Mysliwski A, Slominski A, Wortsman J, Wei ET, Mysliwska J (2002) Corticotropinreleasing hormone affects cytokine production in human HaCaT keratinocytes. Life Sci 70:1013-1021 (Pubitemid 34085093)
523. Zbytek B, Pfeffer LM, Slominski AT (2004) Corticotropin releasing hormone stimulates NFkappa B in human epidermal keratinocytes. J Endocrinol 181:R1-R7 (Pubitemid 38868204)
524. Zbytek B, Pikula M, Slominski RM, Mysliwski A, Wei E, Wortsman J, Slominski AT (2005) Corticotropin-releasing hormone triggers differentiation in HaCaT keratinocytes. Br J Dermatol 152:474-480 (Pubitemid 40547121)
525. Zbytek B, Pfeffer LM, Slominski AT (2006a) CRH inhibits NF-kappa B signaling in human melanocytes. Peptides 27:3276-3283 (Pubitemid 44738166)
526. Zbytek B, Wortsman J, Slominski A (2006b) Characterization of a ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes. Mol Endocrinol 20:2539-2547 (Pubitemid 44496421)
527. Zbytek B, Janjetovic Z, Tuckey RC, Zmijewski MA, Sweatman TW, Jones E, Nguyen MN, Slominski AT (2008) 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. J Invest Dermatol 128:2271-2280
528. Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG (2004) Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305:217 (Pubitemid 38886729)
529. Zhang M, Thurmond RL, Dunford PJ (2007) The histamine H(4) receptor: a novel modulator of inflammatory and immune disorders. Pharmacol Ther 113:594-606 (Pubitemid 46371410)
530. Zhao ZG, Li YY, Yang J, Li HJ, Zhao H (2010) Expression of cannabinoid receptor 2 in squamous cell carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 30:593-595
531. Zheng D, Bode AM, Zhao Q, Cho YY, Zhu F, Ma WY, Dong Z (2008) The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development. Cancer Res 68:3992-3998
532. Zmijewski MA, Slominski AT (2009a) CRF1 receptor splicing in epidermal keratinocytes: potential biological role and environmental regulations. J Cell Physiol 218:593-602
533. Zmijewski MA, Slominski AT (2009b) Modulation of corticotropin releasing factor (CRF) signaling through receptor splicing in mouse pituitary cell line AtT-20-emerging role of soluble isoforms. J Physiol Pharmacol 60(Suppl 4):39-46
534. Zmijewski MA, Slominski AT (2010) Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim Pol 57:1-13
535. Zmijewski MA, Slominski AT (2011) Neuroendocrinology of the skin: an overview and selective analysis. Dermatoendocrinology 3:3-10
536. Zmijewski MA, Sharma RK, Slominski AT (2007) Expression of molecular equivalent of hypothalamic-pituitary-adrenal axis in adult retinal pigment epithelium. J Endocrinol 193:157-169 (Pubitemid 46638542)
537. Zmijewski MA, Li W, Zjawiony JK, Sweatman TW, Chen J, Miller DD, Slominski AT (2009a) Photo-conversion of two epimers (20R and 20S) of pregna-5, 7-diene-3beta, 17alpha, 20-triol and their bioactivity in melanoma cells. Steroids 74:218-228
538. Zmijewski MA, Sweatman TW, Slominski AT (2009b) The melatonin-producing system is fully functional in retinal pigment epithelium (ARPE-19). Mol Cell Endocrinol 307:211-216
539. Zmijewski MA, Li W, Chen J, Kim TK, Zjawiony JK, Sweatman TW, Miller DD, Slominski AT (2011) Synthesis and photochemical transformation of 3beta, 21-dihydroxypregna-5, 7-dien-20-one to novel secosteroids that show anti-melanoma activity. Steroids 76:193-203
540. Zouboulis CC (2004) Acne and sebaceous gland function. Clin Dermatol 22:360-366 (Pubitemid 39535276)
541. Zouboulis CC, Degitz K (2004) Androgen action on human skin-from basic research to clinical significance. Exp Dermatol 13(Suppl 4):5-10 (Pubitemid 39654434)
542. Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M, Scherbaum WA, Orfanos CE, Mccann SM, Bornstein SR (2002) Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA 99:7148-7153 (Pubitemid 34526270)
543. Zouboulis CC, Chen WC, Thornton MJ, Qin K, Rosenfield R (2007) Sexual hormones in human skin. Horm Metab Res 39:85-95 (Pubitemid 46540281)
544. Zouboulis CC, Baron JM, Bohm M, Kippenberger S, Kurzen H, Reichrath J, Thielitz A (2008) Frontiers in sebaceous gland biology and pathology. Exp Dermatol 17:542-551 (Pubitemid 351663284)